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palavras-chave 
 
Sensores de fibra ótica, pressão arterial central, análise da onda de pulso, 
hipertensão, POF, FBG, sensores baseados em intensidade 
resumo 
 
 
Com o presente trabalho pretendeu-se explorar soluções de fibra ótica na 
aquisição da onda de pulso na artéria carótida, para análise da sua morfologia 
e cálculo da pressão arterial central. 
Foram desenvolvidos três sistemas, dois baseados em redes de Bragg, 
gravadas em fibra de sílica, e outro em modulação de intensidade, usando 
fibra ótica de plástico.  
O primeiro sensor foi desenvolvido com o objetivo de testar a exequibilidade da 
utilização de fibra ótica nesta aplicação. Após resultados promissores da sua 
caracterização e testes em sujeitos, o desenvolvimento dos dois sensores 
consequentes teve por objetivo o aumento da sensibilidade e facilidade de 
utilização das sondas, pela melhoria da sua forma, portabilidade e autonomia. 
A solução baseada em intensidade mostrou-se ainda como um sistema que 
coligava desempenho a baixo custo, tendo por isso sido submetida a um 
estudo pré-clínico, comparando o seu desempenho ao de um dispositivo 
comercial, de natureza eletromecânica, numa pequena coorte de indivíduos 
saudáveis. Este estudo teve como objetivo investigar a correlação dos 
resultados obtidos com a sonda de fibra ótica e o dispositivo comercial. 
Tendo-se obtido uma correlação muito forte entre as duas técnicas, o 
dispositivo foi proposto para avaliação clínica. O desempenho da sonda foi 
assim comparado a um dispositivo comercial, numa coorte de indivíduos 
hipertensos. Foram também levados a cabo testes invasivos, usando como 
referência ondas de pressão obtidas no lúmen da artéria aorta em contexto de 
cateterismo cardíaco. Em ambos os estudos clínicos foram obtidos 
coeficientes de correlação muito fortes e diferenças de pressão média na 
gama obtida para dispositivos comerciais. Conclui-se assim que o dispositivo 
baseado em modulação de intensidade surge como uma promissora 
alternativa de baixo custo aos dispositivos eletromecânicos de avaliação de 
pressão arterial central disponíveis no mercado. 
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Optical fibre sensors, central arterial pressure, pulse wave analysis, 
hypertension, POF, FBG, intensity based sensors 
 
abstract 
 
The present study aimed to explore fibre optic solutions in the acquisition of the 
pulse wave in the carotid artery, to its morphology analysis and central arterial 
pressure calculation. 
Three systems were developed, two based on Bragg gratings, engraved in 
silica fibre, and another on intensity modulation, using plastic optical fibre. 
The first sensor was developed in order to test the feasibility of the fibre optics 
use in this application. After promising results in the characterization and small 
tests in subjects, the development of the consequent two sensors had as main 
goals increasing the probes sensitivity and user-friendliness, by improving its 
shape, portability and autonomy. 
The intensity-based solution proved to be the system that best combined 
performance to low cost, and thus was subjected to a pre-clinical study, 
comparing its performance to a commercial device in a small cohort of healthy 
individuals. This study aimed to investigate the correlation between the results 
obtained with the fibre optic probe and the commercial device.  
Having been obtained a very strong correlation between the two techniques, 
the device was proposed for clinical evaluation. The probe’s performance was 
therefore compared to a non-invasive commercial device, in a cohort of 
hypertensive individuals. Invasive testing was also performed, using as 
reference pressure waves obtained in the lumen of the aortic artery in cardiac 
catheterization context.  
In both trials very strong correlation coefficients were obtained, as well as 
medium pressure differences in the range verified for commercial devices. It is 
concluded that the device based on intensity modulation arises as promising 
low cost alternative to central arterial pressure assessment electromechanical 
devices available in the market. 
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1.1. Motivation  
Cardiovascular diseases (CVDs) are the prime cause of death in developed countries, 
and consequently worldwide organizations have been gathering efforts to evolve 
strategies to counteract this trend. In the 2016 “European guidelines on cardiovascular 
disease prevention in clinical practice”, cardiovascular (CV) prevention is defined as a 
coordinated set of actions at the population level or targeted at an individual, that aim to 
eliminate or minimize the impact of CVDs and their related disabilities (Piepoli et al. 2016). 
When the subject-matter is CVDs, prevention has a key role in reducing its prevalence, 
being not only important to identify the predominant risk factors, as much as make sure 
that the preventive measures are implemented as stated and are translated in death rate 
decreasing. The European task force working on cardiovascular prevention, states that 
the elimination of health risk behaviours would make it possible to prevent at least 80 % of 
CVDs and 40 % of cancers (Piepoli et al. 2016). Portugal is no exception when it comes to 
CVDs, as it can be observed in Fig. 1.1, in the top 10 death causes of 2013, CVDs prevail 
as the main cause (DGS 2015).  
 
 
Figure 1.1. Top ten causes of death in Portugal of 2013 (data from DGS 2015). 
The World Heart Federation stated that the majority of CVDs is caused by risk factors that 
can be controlled, treated or modified, such as high blood pressure (BP), cholesterol 
levels and body mass index (BMI), as well as, smoking habits, sedentary lifestyle and 
diabetes. In terms of attributable deaths, the leading CVD risk factor is high BP (with 13 % 
of global deaths attributed), followed by tobacco use (9 %), raised blood glucose (6 %), 
0,0 10,0 20,0 30,0
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physical inactivity (6 %) and overweight, and obesity (5 %). On the other hand, there are 
also major CVD risk factors that cannot be controlled, such as, age, gender and family 
history (WHO 2011).  
Hypertension (HT) is the leading cause of CVDs worldwide, and it is estimated that in 
2025, 1.56 billion adults will be living with HT (WHO 2016). Risk stratification is of extreme 
importance, since only a small fraction of the hypertensive population has a BP elevation 
alone, with its majority exhibiting additional CV risk factors. Moreover, when concomitantly 
present, HT and other CV risk factors have not a simple additive effect, they potentiate 
each other in an exponential way, leading to a total CV risk that is greater than the sum of 
its individual components. The cardiovascular risk factors, besides HT, are presented on 
Fig. 1.2, being male gender (at younger age), age, smoking habits, high levels of 
cholesterol and triglycerides, diabetes, obesity and family history (Mancia et al. 2013). 
 
Figure 1.2. Risk factors, besides HT, influencing CVD prognosis (HDL - high density 
lipoprotein, LDL - low density lipoprotein, y - years) (data from Mancia et al. 2013). 
•Male sex
Gender
•Men ≥ 55 y; Women ≥ 65 y
Age
Smoking habits
•Total cholesterol > 190 mg/dl and/or
•HDL cholesterol: < 40 mg/dl (men); < 46 mg/dl (women) 
and/or
•LDL cholesterol >115 mg/dl
•Triglicerides > 150 mg/dl
Dyslipidemia
•Fasting plasma glucose (102-125 mg/dl)
•Abnormal glucose tolerance test
Compromised glucose regulation
•BMI ≥ 30 kg/m3 and/or
•Waist circumference: men ≥ 102 cm; women ≥ 88 cm
Obesity
•Men < 55 y; Women < 65 y
Family history of permature CVD
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An ideal scenario would be for all adults to have their CVD risk assessed, however that is 
not always practicable. Physicians evaluate cardiovascular risk every day and risk charts 
are important to standardize the risk assessment process. Apparently healthy subjects’ 
total risk should be assessed by using the systematic coronary risk evaluation (SCORE) 
charts. On the other hand, people with established CVDs are already at very high risk of 
further events and need rapid intervention on all risk factors (Piepoli et al. 2016). SCORE 
is a risk chart with the aim to estimate the 10-year risk of a first fatal atherosclerotic event, 
whether heart attack, stroke, aneurysm of the aorta, or other. Distinction is made between 
countries with high and low CV risk, being the latter the case of Portugal. The SCORE 
charts for low risk European countries are presented in Fig. 1.3. The charts retrieve the 
10-year CV risk, taking in consideration the subject’s age, smoking status, cholesterol 
level and brachial systolic arterial pressure (SP), attributing the percentage in the square 
corresponding to the overall subject’s parameters. 
 
Figure 1.3. SCORE chart for 10-year risk of fatal CVD in countries with low CVD risk 
(adapted from the European SCORE Memocard). 
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A key factor on cardiovascular prevention is thus HT control, once it is responsible for a 
great part of cardiovascular events, such as cerebrovascular accidents and ischemic heart 
disease (Safar et al. 2003). The last “European Guidelines for the management of arterial 
hypertension” report an overall prevalence of HT in around 30 to 45 % of the general 
population, increasing sharply with age. HT is known as the “silent killer” and therefore 
many people who suffer from this condition are unaware of it. As stroke major cause, HT 
prevalence in different countries is usually assessed using its mortality rate as surrogate 
(Mancia et al. 2013).  
The approaches for HT monitoring and treatment have changed over time. The first 
accurate description of how blood is pumped throughout the body by the heart was made 
by William Harvey in 1628, in his book entitled “Exercitatio Anatomica de Motu Cordis et 
Sanguinis in Animalibus” (“An Anatomical Study of the Motion of the Heart and of the 
Blood in Animals”) (BBC 2016). More than a century later, Stephen Hales (1677-1761) 
reported the first direct invasive measurement of blood pressure on animals (Lewis 1994).  
Another century passed until, in 1863, Étienne-Jules Marey introduced the first graphic 
method for arterial pulse wave recording (Fig. 1.4a). The created device used a 
mechanical membrane and a lever system to write the radial pulse waveform directly on 
smoked paper (Marey 1863; Avolio et al. 2010). In his studies, Marey remarked pulse 
characteristic differences between young and old subjects, having verified a prominent 
late systolic augmentation in the latter.  
The pulse wave changes, from the youth to older age, were later confirmed by Mahomed 
in the 1870s, noticing similar pulse waveform changes between asymptomatic subjects 
with elevated arterial pressure and the elderly (Mahomed 1872). In the beginning of the 
twentieth century, arterial pulse wave morphology was used by life insurance companies 
to accept or decline applicants, on the basis of their arterial conditions (O’Rourke and 
Nichols 2005). The non-invasive measure of brachial pressure was enabled in 1896 by 
Riva-Rocci, who published the invention of the mercury sphygmomanometer, 
schematically showed in Fig. 1.4b (Riva-Rocci 1896).  
During the third decade of the past century, the development of the electrocardiogram and 
occlusive cuffs for blood pressure measurement, lead clinicians to focus on the extreme 
values of blood pressure (Vlachopoulos et al. 2000; Avolio et al. 2010).  
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a)                                                                       b) 
Figure 1.4. Diagrams of: a) Marey’s device for arterial pulse assessment (Marey 1863) and  
b) Riva-Rocci’s mercury sphygmomanometer (Janeway 1904). 
For the subsequent decades, diastolic arterial pressure (DP) values were considered best 
predictors of cardiovascular diseases. The resistance that the heart had to overcome was 
measured by DP, while SP represented the cardiac strength. At that time, the high SP 
was considered to have a positive CV outcome, whereas it is now known that SP value 
represents the pressure that the left ventricle have to overcome in each systole. 
Only in the seventies and eighties, Kannel et al. demonstrated that SP was a better 
predictor for coronary and stroke events, changing completely the hypertension treatment 
paradigm (Kannel et al. 1971; 1981). Another interesting turn key moment happened in 
1989, when Darne et al. drew attention to pulse pressure (PP - difference between 
diastolic and systolic pressures) as an important CVD risk factor (Darne et al. 1989). 
Since then, growing evidence has emerged, indicating that this index of the pulsatile 
component of blood pressure was a strong predictor of CV events. Associated with that 
concept, it was also found that in older patients, the lower the DP, the higher the event 
rate (Vlachopoulos et al. 2000).  
In the past two decades, blood pressure measurement and HT diagnosis and control have 
been made by assessing the extreme values of peripheral arterial pressure (SP and DP) 
using sphygmomanometers. Currently, a subject is considered hypertensive when 
presenting office BP values of SP ≥ 140 mmHg and/or DP ≥ 90 mmHg, within at least two 
BP measures taken in sitting position in two separate visits, using a validated device. The 
different BP categories currently considered are presented on Table 1.1. 
Several other studies have shown that HT diagnosis should not be performed only based 
in the standard office BP measurements, but also by taking in consideration out-of-office 
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BP values or, if available, 24-hour ambulatory BP monitoring (ABPM24) data, whose 
thresholds are presented on Table 1.2 (Mancia et al. 2013).  
Table 1.1. HT categories accordingly to office BP levels (data from Mancia et al. 2013) 
Category 
SP 
(mmHg) 
 
DP 
(mmHg) 
Optimal < 120 and < 80 
Normal 120 -129 and/or 80-84 
High normal 130 -139 and/or 85-89 
Grade I HT 140 -159 and/or 90-99 
Grade II HT 160 -179 and/or 100-109 
Grade III HT ≥  180 and/or ≥  110 
Isolated systolic HT ≥  140 and < 90 
 
Table 1.2. HT diagnosis thresholds accordingly to office, ABPM24 and home BP values 
(data from Mancia et al. 2013) 
Category 
SP 
(mmHg) 
 
DP 
(mmHg) 
Office BP ≥  140 and/or ≥  90 
Home BP ≥  135 and/or ≥  85 
ABPM24    
  Day time (or awake) ≥  135 and/or ≥  85 
  Night time (or asleep) ≥  120 and/or ≥  70 
  24-hours ≥  130 and/or ≥  80 
 
AMBP24 involves measuring BP at regular intervals (usually every 15 and 30 minutes, in 
day and night time, respectively) over a 24-hour period, while patients undergo normal 
daily activities, including sleep. This ambulatory monitoring technique has the advantages 
of excluding white coat and masked HT, allowing also the monitoring of the BP 
decrease/increase patterns during night, day, and sleep/awake transition.  The cut-off 
value for home BP (or daytime ambulatory BP) is 135/85 mmHg. ABMP24 had become 
the gold-standard in HT diagnosis and is now widely applied (Mesquita-Bastos et al. 
2010).  
Concurrently, several studies have been demonstrating that the arterial systolic pressure 
in aorta, usually known as central systolic pressure (cSP), cannot be directly inferred from 
brachial values (O’Rourke 1990; Roman et al. 2007). The publication of the “Conduit 
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Artery Function Evaluation” study had a major impact on hypertension approach, since it 
was the first report demonstrating significant differences in cSP reduction, between patient 
groups treated with different antihypertensive regimens, even though brachial SP was 
comparably lowered (Williams et al. 2006; Miyashita et al. 2012). This study showed that 
the effects of antihypertensive drug treatments on brachial BP do not invariably reflect 
those seen on central pressure.  Consequently, the research on hypertension monitoring 
and treatment have been changing, clarifying the importance of cSP and arterial stiffness 
assessment for a proper risk stratification in the hypertensive population (Avolio et al. 
2010). 
It can be concluded, as exposed by the European Societies of Hypertension (ESH) and 
Cardiology (ESC), as well as by several scientific studies (Avolio et al. 2009; 
Mesquita-Bastos et al. 2010; Benetos et al. 2011; Chirinos et al. 2012; Mancia et al. 
2013), that HT monitoring, should be performed by self-measurements at home, ABPM24, 
central arterial stiffness evaluation with the assessment of aortic pulse wave velocity 
(PWV) and analysis (PWA), cSP, cPP and central-to-peripheral pressure amplification.  
The guidelines acknowledged the non-invasive methods for the assessment of central 
hemodynamic parameters, but highlighted the need for large scale interventional studies 
for further confirmation of the prognostic importance of central blood pressure. cSP 
evaluation is not set in clinical practice, even though its clinical evidence as predictive 
value for CVDs (Roman et al. 2007; Pini et al. 2008; McEniery et al. 2014). The main 
motives that can be pointed out for the overall reluctance in performing those 
measurements are: the amount of training need to perform the measurements correctly, 
the lack of stablished threshold values for some pulse wave parameters and the overall 
high cost of pulse acquisition devices. For all the mentioned, it is safe to say that the 
development of easy to use, robust and low cost devices to assess central haemodynamic 
parameters is a need in the cardiology field. In the present work, it was studied the 
feasibility of optical fibre sensors as new sensitive and low cost methods for arterial pulse 
wave acquisition. 
Modern optical fibre sensors (OFSs) owe their development to two of the great scientific 
advances made in the 1960s: the laser (1960), by Theodore Maiman, and the optical fibre 
(1966), originality created for telecommunications, by Charles Kao. The first experiments 
on low loss optical fibres being used for sensing purposes, go back to the 1970s (Grattan 
and Sun 2000). To the present, several worldwide research groups investigate new 
configurations of optical fibre devices for sensing and measurement, using a multiplicity of 
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fibres and configurations. Although several decades have passed since the introduction of 
OFSs, and despite their advantages with respect to other mature technologies, only since 
the last decade OFS had their market growing notably, thanks to the improvement of key 
optical components and to the decrease of the associated costs (Taffoni et al. 2013). 
OFS have great advantages when compared with conventional transducers, especially for 
biomedical applications, due to its high accuracy, robustness, small size and light weight, 
electrical isolation from the patient, which makes them intrinsically safer than electronic 
sensors; immunity to electromagnetic interference, being also biocompatible and easy to 
sterilize (Silvestri and Schena 2011; Alberto et al. 2013). 
Their unique features make them promising sensors for biomedical applications, namely 
using fibre Bragg gratings (FBG), written in silica optical fibres (SOF), and intensity 
modulation, with plastic optical fibres (POF), as reported in several publications (Mishra 
et al. 2011; Roriz et al. 2013; Poeggel et al. 2015).  
Optical fibres began to be applied in the biomedical field with the purpose of illuminating 
internal organs during endoscopic procedures. During the years, the same technology has 
been adopted to perform other tasks like laser treatments, and to develop transducers for 
monitoring parameters of interest for both therapeutic and diagnostic purposes 
(Taffoni et al. 2013). OFS are now widely studied and applied in numerous medical 
applications, from non-invasive (Quandt et al. 2015) and minimally-invasive monitoring 
(O’Keeffe 2015) of physical properties, such as heart and respiratory rates (Petrovic et al. 
2014), to more specific biochemical sensing, such as DNA (Giannetti et al. 2015). 
1.2. Main goals and methodology 
The present work had the main goal of testing the feasibility of optical fibre technology 
application to central arterial pulse wave acquisition. After the first applicability tests using 
FBGs, the work progression was planned towards the development and validation of a low 
cost, reliable and robust solution to central arterial pulse acquisition for PWA and cSP 
evaluations.  
The arterial pulse causes distension movements in the order of the 300-400 μm (Benetos 
et al. 1993; Krejza et al. 2006). In this work, it was specified a goal resolution of at least 
1-5 μm. Each developed sensor that met this requirement was tested in human individuals 
to assess the sensors performance and accuracy, root-mean-square deviation (RMSD) 
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was evaluated, regularly also presented in percentage (RMSD%).  Only solutions able to 
assess arterial pulses sequences with at least 6 stable pulses, differing less than 10 % 
between them, were considered to fulfil the required performance. 
A second goal was the manufacturing cost optimization, for which intensity based sensors 
were developed and tested. Once obtained a low cost solution with sensitivity and 
resolution according to the requirements, the probe was submitted to a small test 
comparing it with a commercial non-invasive electromechanical device in young 
individuals, in order to gather data supporting the optical probe implementation in clinical 
environment. In this work this testing stage is denominated as pre-clinical study.  
After this study, which retrieved supporting data to the probe proposal for clinical 
evaluation. The intensity based solution was lastly clinically evaluated by testing it against 
a non-invasive electromechanical commercial device and invasive central pressure data 
acquired in the ascending aorta.   
1.3. Thesis organization  
This document is divided in eight chapters describing the process of development and 
testing of the fibre optic solutions for central hemodynamic monitoring, as well as, it is also 
presented the results from the clinical evaluation of the probe with the best manufacturing 
cost/reliability relation, accordingly with the proposed PhD work plan. In the current 
chapter is described the work context, the motivation for its development, the thesis 
structure and organization, finalizing with the main scientific contributions.  
In Chapter 2, the main principles on central haemodynamics, arterial stiffness indexes and 
central pressure assessment commercial devices are presented. The theoretical 
background continues through the Chapter 3, where the fundamentals on optical fibre 
sensors, more specifically using FBG and intensity configuration, are described.  
The developed probes are presented on Chapter 4, being divided in three parts respecting 
to each developed solution. The first section (4.1) regards the first feasibility test with 
FBGs, for which a probe named FBGbox was developed. In the section 4.2, an improved 
version of the FBG solution is presented. This second probe, designated as FBGpen, 
presented improvements in the shape, to a more user-friendly approach, in sensitivity and 
portability. After developing these two solutions, the research progressed towards the 
manufacturing cost reduction, applying an intensity configuration using POF, resulting in 
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the probe referred to as POFpen, which is presented in section 4.3. The contents on this 
chapter were previously published as: 
 Leitão C, Bilro L, Alberto N, Antunes P, Lima H, et al., “Feasibility studies of Bragg 
probe for non-invasive carotid pulse waveform assessment,” Journal of Biomedical 
Optics, 18:017006, 2013 (section 4.1); 
 Leitão C, Antunes P, André P, Pinto J, Bastos J, “Central arterial pulse waveform 
acquisition with a portable pen-like optical fibre sensor”, Blood Pressure Monitoring 
Journal, 20 (1):43-6, 2015 (section 4.2); 
 Leitão C, Antunes P, Bastos J, Pinto J, André P, “Plastic Optical Fibre Sensor for 
Noninvasive Arterial Pulse Waveform Monitoring”, IEEE Sensors Journal, 15 
(1):14-18, 2015 (section 4.3); 
 Leitão C, Gonçalves S, Antunes P, Pinto J, Bastos J, André P, “Central arterial 
pressure assessment with intensity POF sensor”, Proc. SPIE, 24th International 
Conference on Optical Fibre Sensors, 9634:963424, 2015 (section 4.3); 
 Leitão C, Antunes P, Pinto J, Bastos J, André P, “Optical fiber sensors for central 
arterial pressure monitoring”, Optical and Quantum Electronics, 48 (3):218, 2016 
(section 4.3). 
 
In Chapter 5, the POFpen pre-clinical testing results are presented, which aimed to study 
its aptitude to be introduced in broader clinical studies, by analysing its accuracy, 
applicability and correlation with the results of a commercial device. Only POFpen was 
proposed to be clinically tested because it was the most advantageous probe in terms of 
working principle and manufacturing costs. The contents of this chapter were published 
as: 
 Leitão C, Antunes P, Pinto J, Bastos J, André P, “Carotid distension waves 
acquired with a fiber sensor as an alternative to tonometry for central arterial 
systolic pressure assessment in young subjects”, Measurement, 95:45-49, 2017. 
Chapter 6 reports the non-invasive clinical evaluation of POFpen, performed in the 
cardiology service of “Centro Hospitalar do Baixo Vouga” (CHBV), using as reference a 
commercially available and widely used piezoelectric device. Following, the invasive 
validation performed in the “Unidade de Intervenção Cardiovascular” of “Centro Hospitalar 
e Universitário de Coimbra – Hospital Geral” (CHUC-HG) is described in Chapter 7. The 
contents of both chapters will be submitted to publication as: 
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 Leitão C, Ribau V, Afreixo V, Antunes P, André P, Pinto J, Boutouyrie P, 
Laurent S, Bastos J, “Clinical evaluation of an optical fibre sensor in the 
assessment of the central arterial pulse waves”, to be submitted to Journal of 
Hypertension. 
The content of chapter 7 has already been partially published as: 
 Leitão C, Antunes P, Afreixo V, Andre P, Pinto L, Fernandes R, Costa M, Bastos J, 
“Comparison study of carotid distension waves measured with a non-invasive 
optical fibre sensor and aortic invasive pressure waves”, 26th European Meeting 
on Hypertension and Cardiovascular Protection, Journal of Hypertension, Vol 34, 
e-Supplement 2, Paris, September 2016. 
In Chapter 8, the final remarks are presented, in which the main conclusions and future 
work perspectives are discussed.  
The references and the publications and communications, made within the scope of this 
work, are accessible in the end of the document.  
1.4. Main contributions 
The main contributions of the developed work within this PhD thesis were the design, 
conception and testing of novel sensors for arterial pulse assessment based on optical 
fibre technology, and can be summarized as follows: 
 Development of two working prototypes, based on FBGs, for the assessment of 
carotid pulses and calculation of arterial stiffness indexes and central systolic 
pressure (Chapter 4); 
 Development of a simple, robust, portable and low cost solution based on intensity 
modulation (Chapter 4); 
 Pre-clinical studies to ascertain the aptitude of POFpen introduction in broad 
clinical trials (Chapter 5); 
 Non-invasive POFpen clinical evaluation against a reference device used 
worldwide for arterial pulse assessment, obtaining highly correlated results to the 
commercial device (Chapter 6);  
 Invasive evaluation of POFpen, using as reference intra-aortic pressure waves 
acquired in catheterization context (Chapter 7). 
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The main goal of this work was to develop optical fibre sensors to perform central 
haemodynamics assessment through the evaluation of pulse morphology and cSP. In 
order to fully understand the measured parameters, in this section the fundamentals on 
arterial anatomy and haemodynamic concepts such as flow, resistance and pressure are 
presented. This theoretical background will then focus on the effects of arterial stiffening 
at the central arterial level, and its impact on arterial pulse waveform and cSP. The 
contents are remarked with the state-of-the-art of commercial devices for arterial pulse 
acquisition as well as the methods used in their comparison and clinical evaluation. 
2 
Principles on central haemodynamics and 
pressure assessment devices 
 
 
 
: 
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2.1. Cardiovascular system and arterial anatomy 
The cardiovascular system, also known as circulatory system, is a closed circuit 
composed by three fundamental components: heart, blood and vessels (arteries, veins 
and capillaries). The heart is a hollow muscular contractile organ divided in four 
chambers, two atria and two ventricles. The left side of the heart has the role of 
maintaining the pressure gradient needed for systemic circulation, while the right side is 
responsible for the pulmonary circulation.  
For the systemic circulation, oxygenated blood is ejected from the left ventricle, flowing 
throughout the arteries and arterioles, to the capillaries located in the multiple body 
tissues. From the tissue capillaries, the deoxygenated blood returns, by the venous 
system, to the right atrium of the heart. After what in the pulmonary circulation, blood flows 
to the right ventricle, being pumped throughout the pulmonary artery to be oxygenated in 
the alveoli capillary beds. The oxygenated blood returns to the heart, entering the left 
atrium by the pulmonary vein, beginning a new circulatory cycle (Marieb and Hoehn 
2012). The arteries always transport blood away from the heart and veins carry blood 
towards the heart. In Fig. 2.1, the higher calibre arteries and veins can be schematically 
seen. Within the scope of this work, the theoretic background is focused only in the 
systemic circulation. 
Each cardiac cycle is divided in two main moments, systole (ventricular contraction and 
blood ejection) and diastole (ventricular relaxation and blood filling). At the beginning of 
the systole, pressure rises rapidly in the left ventricle, exceeding the aortic pressure in a 
very short period of time. When that happens, the aortic valve opens, the blood is ejected, 
and the aortic pressure rises. About half way through ejection, both pressures equalize, 
creating an adverse pressure gradient across the aortic valve, being maintained as both 
pressures start to fall, until the aortic valve closure (Bortolotto and Safar 2006). At this 
point, and due to its elastic nature, the pressure in the aorta falls slower than in the 
ventricle, as it acts as a reservoir during systole, storing ejected blood that is then forced 
out into the peripheral vessels during diastole (Safar 2007).  
Both arteries and veins have three distinct layers, or tunicas, around the vessel’s lumen. 
The tunica intima contains the endothelium, which forms a continuous surface that aims to 
minimize friction between the blood and the vessels’ wall. The second layer is the tunica 
media, mostly composed by smooth muscle cells and elastin. The activity of the smooth 
muscle is regulated by sympathetic autonomic nervous system and biochemical reactions. 
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The vasodilation/contraction activities of the tunica media are critical in regulating the 
circulatory dynamics, where small changes in vessel diameter greatly influence blood flow 
and pressure. Lastly, the tunica externa or adventitia (the outmost layer), is largely 
composed by collagen fibres, which have the functions of protecting and reinforcing the 
vessels, as well as anchoring them to the surrounding structures (Marieb and 
Hoehn 2012).  
 
 
 
Figure 2.1. Main calibre veins and arteries (adapted from Aviva 2010). 
Considering the arterial features from the heart to the peripheral circulatory system, such 
as calibre, wall structure and function, the arteries can be divided in: elastic, muscular and 
arterioles (see Fig. 2.2). The elastic central arteries have large lumens, making them 
low-resistance pathways that conduct blood from the heart to the medium-sized arteries, 
being for that reason usually referred to as “conducting arteries”. The tunica media of 
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elastic arteries is composed by a high content of elastin laminae, which has the function of 
damp the surges of blood pressure from the heart, acting as a pressure reservoir. 
Therefore, during the systole, when the blood is forced into central arteries, their elastin 
stretches and stores energy. On the other way, during diastole, the fibres recoil and 
release energy, propelling the blood forward, generating an almost continuous blood flow 
to the distributing arteries during all the heart cycle. This is known as the Windkessel 
effect (Westerhof et al. 2009).  
Examples of elastic arteries are the aorta and the common carotids. The aortic luminal 
diameter for women is approximately 29 mm and for men 32 mm (Turkbey et al. 2013), 
while the carotid artery estimated diameter varies from 6.1 mm in women to 6.5 mm in 
men (Krejza et al. 2006). Furthermore, the carotid artery distension is reported to be 
approximately 6.1 % (Benetos et al. 1993), being this value obtained in a cohort of 78 
normal and hypertensive subjects. Applying the presented carotid diameters, the referred 
distension translates in diameter changes of 370 μm and 395 μm, for women and men, 
respectively. 
 
 
Figure 2.2. Representation of the simplified circulatory system, emphasizing the arterial wall 
structure (Adapted from Marieb and Hoehn 2012 and Polak et al. 2016).                                                             
The elastic arteries branch to the muscular arteries, also called “distributing arteries”, 
which deliver blood to specific organs and tissues. Brachial, radial and femoral are 
examples of muscular arteries, whose tunica media is mainly composed by smooth 
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muscle, being the elastin concentrated in the internal and external tunicas. These arteries 
are less distensible than the elastic ones, being more active on vasoconstriction in order 
to control the blood flow (Marieb and Hoehn 2012). In this work, muscular arteries are 
referred to as peripheral arteries. Arterioles are the smallest arteries. Even though the 
larger arterioles have all three tunicas, being their tunica media mainly composed by 
smooth muscle, smaller arterioles, which lead into the capillary beds, can be made from a 
single layer of smooth muscle cells spiralling around the endothelial lining. The instant 
blood flow into the capillary beds is determined by the arteriole diameter, which varies in 
response to changing neural, hormonal, and local biochemistry. When arterioles constrict, 
the tissues are largely bypassed, nonetheless, when arterioles dilate, blood flow into the 
local capillaries can dramatically increase (Marieb and Hoehn 2012). 
2.2. Haemodynamics: blood flow, pressure and resistance 
Three fundamental concepts have to be introduced to understand vascular circulation: 
blood flow (F), blood pressure and peripheral resistance (R). Blood flow corresponds to 
the blood volume that circulates through a vessel, organ or the entire vascular bed in a 
given time unit (usually expressed in ml/min or l/min). As the blood flows through an 
artery, with pressure P1 at the onset and P2 at the end, the pressure difference 
(P = P2 - P1) is imposed by the resistance of that arterial path, being the three 
parameters related as: 
 
P
F
R

 .                                                      (eq. 2.1) 
 
In the specific case of a circular tube complying a steady flow with a parabolic velocity 
profile, as schemed on Fig 2.3, Poiseuille’s law describes the relation between pressure 
change with vessel inner radius (ar), vessel length (al), and blood viscosity (), accordingly 
with:  
r
l
P a
F
a
4
8



 .                                                 (eq. 2.2) 
 
 
Figure 2.3. Factors influencing a steady flow in a tube. 
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Combining equations 2.1 with 2.2, the resistance in a uniform tube can be given by: 
 
4
8 l
r
a
R
a


 .                                                      (eq. 2.3) 
 
Although this relation may not be precisely applicable in the human arterial system, it 
helps to understand how strongly resistance depends on arterial wall radius. Considering 
that blood viscosity and vessel length slowly change through the regular aging process, 
only the radius variation can rapidly be changed by vasoconstriction and vasodilatation, 
impacting dramatically resistance and flow. For this reason, the large arteries close to the 
heart, which do not change dramatically in diameter, contribute little to peripheral 
resistance. Instead, the small-diameter arterioles, which can expand or constrict 
accordingly with the local instantaneous metabolic needs, are the major determinants of 
peripheral resistance (Nichols 1990; Vosse and Stergiopulos 2011). 
BP is the pressure gradient observed through the vascular system, being the driving force 
that keeps the blood flowing. It is defined as the exerted force per unit area of the vessel 
wall, being usually expressed in millimetres of mercury (mmHg). As schemed in Fig. 2.4, 
BP is composed by a steady element, the mean arterial pressure (MAP), and a pulsatile 
component, corresponding to the arterial pulse ranging between DP and SP. The pulsatile 
pressure is usually referred to as pulse pressure. When compared to arterioles, the 
resistance of the large arteries is so low that the MAP is practically the same along its 
path. On small arteries pulsatility drastically decreases to protect microcirculation 
(Muiesan et al. 2013).  
 
Figure 2.4. Pressure, area and resistance variation through the vascular system (adapted 
from Bortolotto and Safar 2006 and Polak et al. 2016). 
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The pulsatile pressure component is the consequence of intermittent ventricular blood 
ejection from the heart, being influenced by several cardiac and vascular factors, such as 
heart rate (HR) and arterial stiffness (Safar et al. 2003). SP and PP increase from the 
aorta to peripheral arteries while mean and DP show only a minor decrease of 1 to 2 
mmHg toward the periphery. The average increase of PP can be as much as 10 to 14 
mmHg, when moving from the aorta to the brachial artery (Safar and Jankowski 2009).  
The SP and PP increase through the proximal arterial tree is known as “pressure 
amplification” and is associated with changes in diameter and elasticity/compliance of the 
involved arteries (Pauca and Wallenhaupt 1992; Weber and Segers 2015). The pressure 
amplification is actually a pulse wave distortion, rather than a true amplification of the 
pressure signal. During systole, the heart generates the pressure wave (forward wave, 
FW), that, as it advances through the arterial tree, suffers reflections caused by the 
non-uniform elasticity and viscous damping within the arterial system. As a consequence, 
a reflected wave component (RW) is created. So, the pulse amplitude amplification and 
“distortion” happens as a result of changes in the relative timings and amplitudes of the 
forward and reflected pressure waves (O’Rourke 1999; Kips 2011). 
 
2.3. Arterial stiffness evaluation 
The arterial elastic properties are given by elastin, which is the most inert substance in the 
body, with a chemical half-life measurable in decades. Elastin fracture is predicted to 
occur after approximately 109 cycles of 8% stretch, which is achieved in the proximal aorta 
within 40 years of life. When elastin fibres, normally bearing central pressure surges, 
begin to fracture, the wall stretches and the elastic arteries dilate. Consequently, with the 
loss of arterial elasticity, the stresses once buffered by elastin are transferred to the less 
extensible collagenous elements in the wall (O’Rourke and Nichols 2005).  
Meinders and Hoeks explained the distension/pressure behaviour by an exponential 
approach, which takes in consideration the arterial cross-sectional area variation in time, 
Acs(t), with the arterial distension, according to: 
2( )
( )
4
d
cs
a t
A t

 ,                                                  (eq. 2.4) 
considering that the artery is rotationally symmetrical, and ad(t) is its diameter in time. The 
Acs(t) peak corresponds to the systolic cross-section and the minimum to the diastolic 
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cross-sectional area, Adiast. The relationship between the pressure wave, pwave, and the 
cross-sectional area variation, can be described as: 
d iast
cs
wave a
A t
p t DP
A
( )
( ) exp 1
 
  
 
,                                       (eq. 2.5) 
where a is the wall rigidity coefficient. This relation can be applied over a large pressure 
range, allowing to calculate local arterial stiffness indexes (Meinders and Hoeks 2004; 
Yuan et al. 2013). In Fig. 2.5 the non-linear relationship between pressure and 
distensibility can be schematically observed as the cross-sectional area in function of 
pressure. The non-linear tendency is greater at higher pressures, when the vessel 
distends less due to the increasing recruitment of collagen fibres on the stretched vessel 
(Kips et al. 2010).   
 
Figure 2.5. Typical area-pressure relation for an elastic artery showing the 
pressure/distension nonlinear behaviour. 
The central arterial stiffness progression can be translated in several changes in the 
arterial pulse morphology, velocity and pressure values (Mitchell et al. 2004), which are all 
features that can be used as surrogates for arterial stiffness (Laurent et al. 2006).  
In normal central elastic arteries, as previously described, the elastin expand during 
systole, storing energy, which is then liberated during diastole by elastin recoil. The elastic 
central arteries are characterized by low velocity of the arterial pulse propagation, in the 
order of the 6 m/s (Briet et al. 2012), as well as a sharp impedance mismatch in the elastic 
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to muscular arterial transition. A direct consequence of the arterial wall’s elasticity and 
compliance is the phase shift of the arterial pulse, whose shape changes throughout the 
arterial path and its amplitude increase, as can be observed in Fig. 2.6a (Vosse and 
Stergiopulos 2011). The pulse suffers reflections majorly in the impedance mismatch 
between elastic and muscular arteries, limiting the transmission of pulsatile pressure 
energy to the periphery, protecting the microcirculation. At the heart, the reflected wave 
arrival during diastole, as schemed in Fig. 2.6b, has the physiological role of promoting an 
efficient coronary perfusion (London and Pannier 2010; Safar 2010; Muiesan et al. 2013).  
 
a) 
 
 b) 
Figure 2.6. Schematization of the physiological effects of central arterial elasticity: a) arterial 
pulse throughout the arterial path (adapted from Briet et al. 2012); b) central pulse of elastic 
central arteries, representing the combination of the forward with the reflected wave, 
(tSystole - systole duration; tDiastole - diastole duration).  
 
With central arterial aging, the elastic walls become gradually stiffer, as the muscular 
arteries maintain their features. This causes the decreasing or even inversion of the 
impedance gradient from elastic to muscular arteries, as central PWV becomes equal or 
even higher than in muscular arteries. The overall aortic stiffning process features four 
stages, accordingly to the detailed aging cardiovascular continuum described in O’Rourke 
et al. 2010. The first stage corresponds to the normal aortic elastic fibres fatigue during 
life, with the gradual fracture and fraying of the elastic lamellae, that on the other hand 
cause the distension and arterial remodelling, and consequently the typical aortic 
stiffening. The second stage has to do with the multiplicative effect of the aortic stiffening 
in increasing both resistance and early wave reflections, resulting in the pulsations cannot 
be dampened by the elastic aorta (third stage), extending peripherally into the 
microvasculature, as schemed in Fig. 2.7a (O’Rourke et al. 2010; Muiesan et al. 2013), 
especially into the small arteries of organs with high resting blood flow, which are the 
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cases of the brain (Mitchell et al. 2011) and kidney (Briet et al. 2012). The fourth stage is 
related with the raise in aortic pulse pressure associated to arterial stiffening, which leads 
to an increase in cSP and a decrease of DP (Fig. 2.7b), affecting coronary perfusion and 
augmenting the risk of myocardial ischemia (Nichols 2005). Furthermore, once during the 
systole the left ventricle’s pressure approach the aortic systolic pressure, the latter is a 
major determinant of myocardium’s blood supply needs. Consequently, as cSP increases, 
also does the risk of left ventricle hypertrophy (O’Rourke et al. 2010).  
 
a) 
 
b) 
Figure 2.7. Pathological effects of central arterial stiffness: a) arterial pulse throughout the 
arterial path (adapted from Briet et al. 2012); b) central arterial pulse of stiff central arteries, 
representing the combination of the forward with the reflected wave  
(tSystole - systole duration; tDiastole - diastole duration). 
2.3.1. Pulse wave velocity 
Once the pulse pressure is propagated throughout the arterial tree as a wave, it is 
possible to calculate the wave’s velocity from the time delay (t) between two arterial 
pulses acquired at different sites of the arterial tract, knowing the distance between them 
(s):  
s
PWV
t



.                                                 (eq. 2.6)  
PWV is used as a surrogate for arterial stiffness, based on the Moens-Korteweg equation: 
h
r
Ea
PWV
ρa2
 ,                                            (eq. 2.7) 
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where E is the Young’s modulus of the arterial wall tissue,  ah is the wall thickness, ρ is 
the blood density, and ar is the internal radius of the artery (Bramwell and Hill 1922; 
Laurent et al. 2006). PWV is usually assessed between carotid and femoral arteries, 
covering the entire aorta pathway. For pulse transit time/time delay calculation, carotid 
and femoral pulses are obtained transcutaneous at the right common carotid and femoral 
arteries (Laurent et al. 2006) and the distance between sites should be considered as 
80% of the direct external distance (cf), as schemed in Fig. 2.8 (Van Bortel et al. 2012; 
Mancia et al. 2013).  
 
Figura 2.8. Scheme of the carotid-femoral PWV measurement  
(adapted from Laurent et al. 2006). 
The carotid and femoral pulses can be either recorded simultaneously, as with the 
Complior device (Alam Medical), or sequentially using a single probe, in which the carotid-
femoral pulse transit time is determined with reference to the R-wave of the 
electrocardiogram signal, which is the method used by in the SphygmoCor device (AtCor 
Medical) (Qasem et al. 2008; Van Bortel et al. 2012). The used arterial pulses can be from 
various natures, including pressure, distension, and flow (Laurent et al. 2006).  
The carotid-femoral PWV is considered the gold-standard measurement to evaluate 
arterial stiffness (Laurent et al. 2006). The strong scientific evidence turned PWV in a 
recognized surrogate for arterial stiffness evaluation, being now the most recurrently used 
in cardiovascular risk stratification and prognosis (Laurent et al. 2001; Laurent et al. 2003; 
Mitchell et al. 2010). Accordingly to the European guidelines for the management of 
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arterial hypertension, a PWV value higher than 10 m/s is considered a subclinical organ 
damage (Mancia et al. 2013). 
In 2010, Boutouyrie and Vermeersch, collected data from 16 867 subjects across eight 
European countries, in which PWV and basic clinical parameters were measured. This 
study established reference PWV values to different ages and BP categories, which are 
presented in the Table 2.1. As an example, it can be verified that for subjects with optimal 
to high normal BP, the mean PWV ranged from 6.1 m/s for healthy subjects with less than 
30 years old, to 11.8 m/s for subjects ≥  70 years old (Boutouyrie and Vermeersch 2010).  
 
Table 2.1. Reference values for PWV (m/s) accordingly with age and BP category since 
optimal to grade II/III hypertension (data from Boutouyrie and Vermeersch 2010). 
Age 
category 
Optimal 
BP 
Normal 
BP 
High 
normal BP 
Grade I  
HT 
Grade II/III 
HT 
<30 6.1 6.6 6.8 7.4 7.7 
30-39 6.6 6.8 7.1 7.3 8.2 
40-49 7.0 7.5 7.9 8.6 9.8 
50-59 7.6 8.4 8.8 9.6 10.5 
60-69 9.1 9.7 10.3 11.1 12.2 
≥70 10.4 11.7 11.8 12.9 14.0 
2.3.2. Pulse wave analysis 
In the “Expert consensus document on arterial stiffness: methodological issues and 
clinical applications” is stated that PWA should be analysed through tree major 
parameters: augmentation index (AIx), cPP and cSP (Laurent et al. 2006). The main 
advantage of using PWA for arterial stiffness assessment, is that it can be performed 
using only one measurement site, such as the carotid artery. In this section concepts and 
clinical data on pulse wave analysis are presented. 
Augmentation index 
The pulse waveform is composed by the FW produced by the heart during systole and the 
RW, which is the sum of the reflections of the original wave, created in impedance 
mismatches in the arterial tree. Murgo et al. reported different types of carotid waveforms 
that can be assessed in humans, which can be observed on Fig 2.9 (Murgo et al. 1980).  
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In subjects with elastic central arteries it is expected to see the so-called “type-C” wave, 
where the cSP corresponds to the FW produced by the heart, defining the systolic 
pressure value, with the RW arriving in the late systole creating an inflection.  
 
Figure 2.9. Murgo’s wave types. 
With aging and central arterial stiffening, the RW tends to arrive earlier in the heart cycle, 
forming a second peak with approximately the same amplitude than the first (FW), being 
the case of the “type-B” wave. With the PWV increasing, the reflected wave arrives even 
earlier in the systole, being added to the FW in such way that there is an increasing of the 
systolic pressure, which is the case of the “type-A” wave (Murgo et al. 1980). Finally, in 
the extreme case of arterial reflections, both waves overlap in a manner that no inflexion 
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can be identified, being the case of the “type-D” wave. Through the aging process, an 
individual can present all four wave types (Kelly et al. 1989). 
 
The AIx is the most well-known measure of pulse wave reflection and purposes to quantify 
the impact of wave reflection on the pulse wave contour, which severely changes with age 
(Kelly et al. 1989; Mitchell et al. 2004). AIx can be calculated applying eq. 2.8, being also 
frequently represented as percentage (AIx%).  
RW-FW
AIx=
cPP
                                                 (eq. 2.8) 
The AIx can be negative, for “type-C” waves, or positive, for “type-A” waves (Weber and 
Segers 2015). The augmentation index has the advantages of not depend of pressure 
calibration, being dimensionless, and can be derived directly from the carotid pulse wave. 
However, it has the disadvantages related to the influence of the magnitude and timing of 
wave reflection, which are sensitive to factors such as the individual’s height and heart 
rate (Wilkinson et al. 2000).  
In 2006, Wojciechowska et al. determined AIx thresholds for age category, by analysing 
AIx values from 534 subjects without hypertension, diabetes, or previous nor concomitant 
cardiovascular disease (Table 2.2) (Wojciechowska et al. 2006). Latter, in Janner et al. 
2010, were presented reference equations to calculate the expected AIx of a subject, 
considering their age, HR, and height for women (eq. 2.9) and men (eq. 2.10). 
Table 2.2. AIx% proposed thresholds for men and women by age (years) 
(data from Wojciechowska et al. 2006). 
Age AIx% men AIx% women 
20 10 17 
30 22 29 
40 30 37 
50 37 44 
60 41 48 
 
AIx = 56.28 + 0.90age - 0.005age2 - 0.34HR - 0.24height              (eq. 2.9) 
AIx = 79.20 + 0.63age - 0.002age2 - 0.28HR - 0.39height            (eq. 2.10) 
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Even though AIx is being mostly reported as an arterial stiffness index, it is not only 
dependent on arterial stiffening and consequent acceleration of the pulse wave. 
London et al. studied a cohort of 180 patients with end-stage renal disease who 
underwent aortic PWV measurement and determination of arterial wave reflexions, 
expressed as AIx, by applanation tonometry on the common carotid artery. This study 
reported a persistent association of AIx with mortality of patients with normal PWV in 
end-stage renal failure. The intensity of the reflected wave is dependent on reflective 
properties on the vascular tree that can be independent from arterial stiffening (London 
et al. 2001).  
Several studies have shown the predictive value of AIx. In a meta-analysis including 11 
longitudinal studies, employing central haemodynamic measures from 5648 subjects in a 
mean follow-up of 45 months, it was concluded that AIx predicts clinical events 
independently of peripheral pressures (Vlachopoulos et al. 2010).  Others works also 
related AIx with hypertension (Kaess et al. 2012) and coronary arterial disease (Weber 
et al. 2004; Ueda et al. 2004; Chirinos et al. 2005). Matsui et al. showed the correlation of 
AIx with total and low density lipoprotein cholesterol in hypertensive subjects 
(Matsui et al. 2004). The relation of arterial stiffness measured as AIx with a subtype of 
acute ischemic stroke (lacunar infarction) was also verified in Byun et al. 2014. 
Central pulse and systolic pressures 
As introduced before, the arteries irrigating the heart, kidneys, and brain are exposed to 
cSP, rather than peripheral systolic pressure (pSP). The difference between both 
pressures is not constant, so cSP cannot be inferred from brachial pressure as shown by 
McEniery et al. in the Anglo-Cardiff collaborative trial II, which studied the variability of 
cSP and the impact of cardiovascular risk factors. It was demonstrated that cardiovascular 
risk factors affect the pulse pressure amplification, showing data comparing cSP and pSP 
for 5648 healthy subjects, and concluding that cSP cannot be reliably inferred from pSP 
either for healthy or hypertensive subjects. Other conclusion from this study was that 
when stratified by pSP, 70% of the individuals considered as having high-normal blood 
pressure presented cSP values consistent with stage I HT (McEniery et al. 2008). 
A recent study stablished reference values for cSP, in which Herbert et al. gathered cSP 
data from 45 436 subjects in order to stablish normal values of cSP and pressure 
amplification in a healthy population according to age, sex, and pSP. The authors had four 
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study branches: normotensives with and without cardiovascular risks and hypertension 
with and without others risk factors. The normotensives without risk factors were 
considered the “normal population”, and all the other categories were labelled as 
“reference population”. The results from both populations, per age category, are 
presented in Table 2.3. The study reported, for instance, that for the normal population, 
between the ages of 20 to 70 years old, the cSP ranged from 97 to 118 mmHg and 105 to 
116 mmHg for female and male individuals, respectively. On the other hand, for the 
“reference population” the results were significantly higher, the cSP value obtained in the 
normal population above 70 years old, is reached in the age decade between 40 and 49 
years old (Herbert et al. 2014).   
 
Table 2.3. cSP (mmHg) values by age (years) for normal population (normotensives without 
CV risks) and reference population (normotensives with CV risks and hypertensives with or 
without other CV risks) (data from Herbert et al. 2014). 
Age 
category 
Normal population Reference population 
Male Female Male Female 
<20 105 97 109 99 
20-29 103 95 110 101 
30-39 103 98 114 111 
40-49 106 102 118 116 
50-59 110 110 123 120 
60-69 114 114 128 128 
≥70 116 118 135 138 
 
Over time, a compelling body of evidence have been raised in the role of cSP as 
cardiovascular predictor. Boutouyrie et al. showed that cPP was a strong independent 
determinant of carotid artery enlargement and wall thickening, while MAP and peripheral 
PP were not (Boutouyrie et al. 1999). cSP and brachial/carotid PP amplification in a cohort 
of 180 patients with end-stage renal disease undergoing haemodialysis was studied in 
Safar et al. 2002. The patient’s follow-up had a mean duration of 52 ± 36 months, during 
which 70 deaths occurred, from cardiovascular and non-cardiovascular fatal events. cPP, 
brachial/carotid PP amplification, and aortic PWV emerged as all-cause mortality 
predictors in this cohort. On the other hand, brachial pressure, including PP, had no 
predictive value for mortality. The authors concluded that the results provided the first 
direct evidence that, in patients with end-stage renal disease, cPP and, mainly, the 
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disappearance of brachial/carotid PP amplification are strong independent predictors of 
all-cause mortality (Safar et al. 2002). 
In 2007, the Strong Heart Study investigated the relation of cSP with vascular disease and 
cardiovascular outcome. The study evaluated the carotid artery hypertrophy, by 
intima-media thickness (IMT) and vascular mass assessment, the extent of 
atherosclerosis, and the incident cardiovascular events. cSP was obtained by arterial 
radial tonometry. The authors showed that cPP was more strongly related to vascular 
hypertrophy, extent of atherosclerosis, and cardiovascular events than brachial PP 
(Roman et al. 2007).  
In the context of the same study, Roman et al. showed that cPP ≥  50 mmHg predicts 
adverse CVD outcome and might serve as a target in hypertension intervention strategies 
(Roman et al. 2009). In 2010, it was also evaluated the relation between cSP and pSP in 
left ventricular hypertrophy by echocardiography and radial applanation tonometry, 
performed in 2585 subjects. Results suggested that cSP has more impact on left 
ventricular hypertrophy and remodelling stimulation than pSP. However, cPP was of all 
the addressed factors, the most important in causing vascular hypertrophy and 
atherosclerosis (Roman et al. 2010).    
Several studies also report the role of central pressure monitoring in assessing the central 
effectiveness of antihypertensive treatments, as well as new perspectives on hypertension 
treatment and monitoring (Williams et al. 2006; Agabiti-Rosei et al. 2007; Boutouyrie et al. 
2010; Masugata and Senda 2010; McEniery et al. 2014; Pucci et al. 2014). A detailed 
review of the effects on arterial stiffness and reflections per treatment active substance is 
presented in Boutouyrie et al. 2014. 
2.4. State-of-the-art of non-invasive assessment of the arterial pulses 
The gold standard technique to assess central pressure waves is aortic invasive 
catheterization, however as an invasive procedure, is associated with a number of 
potential complications (Woodrow 2000). Currently, the evaluation of the several arterial 
stiffness surrogates is usually performed by arterial tonometry, nevertheless there are 
other non-invasive techniques, based on the acquisition of pressure, flow and distension 
waves, which will be shortly described. 
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Tonometry  
Central pulse waves are usually assessed by arterial applanation tonometry, which 
measures pressure or tension, applying the Laplace law that relates wall tension (T) with 
transmural pressure (Pt), vessel radius (ar) and thickness (ah) of a cylindrical thin wall 
tube, as in eq. 2.11. The transmural pressure is given by the difference between external 
(Pe) and internal (Pi) pressure of the artery. As can be verified in Fig. 2.10, when the 
pressure sensor applanates the tube wall, with Pe, the radius of the artery tends to infinite 
and Pt to zero. Consequently the Pe becomes equal to Pi that can then be measured 
(Miyashita et al. 2012). 
h
r
t
a T
P
a
                                                    (eq. 2.11) 
 
Figure 2.10. Schematic drawing of arterial tonometry principle  
(adapted from Miyashita et al. 2012). 
Tonometry can be performed in several superficial arteries, since underlying hard tissues 
are present to enable a proper artery applanation (Drzewiecki et al. 1983). Tonometry 
data is generally accepted for radial, carotid and femoral arteries, but no consensus exists 
for brachial artery tonometry (Adji and O’Rourke 2012). When the arterial pulses are 
assessed in a peripheral artery, usually the radial, central pressure waves are synthetized 
using population-based generalized transfer functions (GTFs), applied in time or 
frequency domains. GTFs can be simplistically viewed as sophisticated low pass filters, 
applied to peripheral wave pulses, using the fact that the aortic pressure wave contains 
fewer higher harmonics than the radial wave (Williams et al. 2011). Even though being a 
worldwide applied and accepted procedure, tonometry has the limitation of may induce 
push-pull artefacts due to the motion of the arterial wall and/or operator, and thus might 
distort the shape of the curve (Boutouyrie et al. 2014). 
Underlying tissues
Skin
Tonometer
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Several tonometers for pulse wave acquisition are commercially available, being 
examples of widespread tonometers the SphygmoCor® (AtCor medical, Australia) and the 
Complior Analyse® (Alam Medical, France) (Avolio et al. 2010). The main difference 
between both devices is the probes’ pressure sensors and shape. The SphygmoCor has a 
pen-like shape probe, which uses diffused semiconductor Wheatstone bridge sensors and 
perform acquisitions at 128 Hz, whereas, Complior uses piezoelectric sensors in a 
coin-like shape probe, having an acquisition frequency of 1000 Hz (Stea et al. 2014). 
Photoplethysmography (PPG) 
PPG is a low-cost optical measurement technique that can be used to detect blood 
volume changes in the microvascular bed of fingers, toes and ear lobes. It has been used 
to assess the digital beat-to-beat blood pressure and in its basic form complies only a light 
source to illuminate the tissue (e.g. skin), in red or a near infrared wavelength, and a 
photodetector (PD) to measure light intensity variations associated with changes in blood 
perfusion (Allen 2007). The main disadvantage of PPG is only assessing pressure waves 
in body extremities, being unusable on higher calibre superficial arteries, such as the 
common carotid. A recent example of a commercial PPG device is the pOpmètre® 
(Axelife, France) that assesses finger-toe pulse wave velocity, with the aim of provide a 
more comfortable and easy to routinely measure arterial stiffness (Alivon et al. 2015).  
Oscillometry 
Pulse wave acquisition devices based on oscillometry apply the usual upper arm cuffs to 
acquire the brachial arterial pulse. To assess the pulses, the cuff is pressurized at least 
35mmHg over the actual systolic pressure creating a stop-flow condition where a small 
diaphragm will develop around the brachial artery at the level of the upper edge of the 
over-pressurized cuff. As the pressure changes, the pulse wave critical points will cause a 
beat on the membrane like a drumstick. Because the upper arm tissues are practically 
incompressible, the energy propagates and reaches the skin/over-pressurized cuff edge, 
causing a very small volume/pressure change in the cuff. These very small supra-systolic 
pressure changes are recorded by the pressure sensor in the device (Horváth et al. 2010; 
Weiss et al. 2012). The main disadvantage of such devices is the impossibility to assess 
directly the carotid pulse wave. Nonetheless, the easiness of use has been made these 
devices popular in general clinic, being commercial examples the Arteriograph® 
(Tensiomed, Hungary), Mobil-O-Graph® (I.E.M. GmbH, Germany), Vicorder® (Skidmore 
Medical, United Kingdom), and Omron® HEM-9000AI (Omron Healthcare, Japan). 
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Echotracking 
Distension waves of superficial large arteries can be acquired using non-invasive vascular 
ultrasound wall tracking systems. When an acoustic ultrasound wave (typical frequencies 
between 7 and 12 MHz) propagates through the tissues it is reflected on interfaces with 
acoustic impedance discontinuity. Consequently, when applied to superficial arteries, the 
arterial interfaces lumen-intima and media-externa will reflect the acoustic signal, allowing 
the detection of posterior and anterior arterial wall, permitting the calculation of 
intima-media thickness (Powalowski et al. 2000).  IMT is a commonly used surrogate 
marker of atherosclerosis (Bartgaile 2012), being also a powerful predictor of CVD events 
(Lorenz et al. 2007), specially stroke (Martinez-Sanchez and Alexandrov 2013; Rothwell 
2000). Additionally, the use of multi-frame echotracking enables to assess the 
heterogeneity of the arterial wall on a segment, which is useful to the characterization of 
atherosclerotic plaques (Boutouyrie et al. 2014).  
With these systems, arterial changes in diameter (distension waves) and related 
measures can also be obtained, with a precision of approximately 1 µm (Laurent 
et al. 2006; Kips 2011). Several studies reported the used of scaled distension waves to 
determine carotid artery pressure, using linear or exponential methods (Van Bortel et al. 
2001; Vermeersch et al. 2008 and Kips et al. 2010). In the linear scaled method the 
distension wave is calibrated directly as a pressure wave, whereas, the exponential 
method uses the Meinders and Hoeks distension/pressure relation to reconstruct the 
pressure wave. The use of distension waves arises as an alternative to tonometry, since 
the arterial applanation is not required, facilitating the process of wave acquisition, for 
instance, in obese subjects. Examples of echo-tracking systems are NIUS02® (Asulab, 
Switzerland), Artlab® (Esaote-Pie, the Netherlands), and HDI500® with QLab (Philips, the 
Netherlands). 
Magnetic resonance imaging (MRI) 
Recently, evolutions in imaging techniques, such as MRI, have been enabling the 
assessment of deep arteries, such as aorta, making possible to investigate their true 
arterial geometry and blood flow distribution (Prehn et al. 2009; Boutouyrie et al. 2014). 
MRI allows direct measurement of regional stiffness in the aortic arch (by PWV 
calculation), as well as to analyse distensibility in the ascending and descending aorta. 
The new trends are to combine MRI with arterial tonometry in order to obtain a 
wide-ranging analysis on central haemodynamics, non-invasively relating central pressure 
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with aortic and ventricular morphologies (Redheuil et al. 2011). The main limitations of 
MRI techniques are the low temporal and spatial resolutions, along with, as an imaging 
procedure, being impossible to access local pulse pressure (Boutouyrie et al. 2014). 
2.5. Comparison of pulse wave data from different assessment techniques 
Despite having been published guidelines on the validation of PWV devices (Wilkinson 
et al. 2010), no protocol exists yet to validate PWA and cSP devices (Stergiou et al. 
2016). In the literature analysis it was verified that a great majority of the studies, 
comparing central pulse morphology and cSP assessment techniques, frequently used 
other studies as reference. A few others applied the standard requirements for regular 
brachial sphygmomanometers of the Association for the advancement of medical 
instrumentation (AAMI), which limit the pressure difference between the tested device and 
the reference in 5 mmHg, with a standard deviation (SD) up to 8 mmHg (Wassertheurer 
et al. 2010; Pucci et al. 2013, Stea et al. 2014).  
The correlation between acquired data with POFpen and the non-invasive and invasive 
techniques was performed accordingly to similar studies found on the literature (see 
Table 2.4). Besides AIx and cSP, also the pulse waveforms, in time and frequency 
domains, can be directly compared using some of the approaches next described. 
RMSD is a measure of absolute difference between signals, allowing the quantification of 
the variation between the data points across the entire normalized waveforms, calculated 
between the tested (pwavetest) and the reference (pwaveref) pulse wave data. As showed in 
eq. 2.12, RMSD corresponds to the square root of the mean squared differences between 
the arterial pulses obtained with both techniques, where np is the number of compared 
pulse points.  
                                        
pn
wavetest ,i waveref ,i
ip
RMSD ( p p )
n 
  2
1
1
                       (eq. 2.12) 
 
Other important parameter is the form factor (FF), frequently represented as percentage 
(FF%), relates the mean point of the pulse wave (MAP) with its amplitude, being a 
measure of how “peaked” the waveform is. Through the periphery, the pulse wave is 
distorted and becomes more peaked, consequently its FF becomes lower. It is also 
reported that distension waves have higher FF values than pressure waves, in 
approximately 6% (Kips et al. 2010). The same study discusses that the distension waves 
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are “flatter” than the tonometric waves due to the non-linear pressure-diameter 
relationship, as discussed in section 2.3. This fact is especially evident at higher 
pressures, since the arteries are stretched, the vessel distend less with the collagen fibres 
recruitment. At the central level, FF can be calculated as: 
      
cSP
DPMAP
FF
-
= .                                             (eq. 2.13)                                       
In some studies, the agreement analysis between waves is also performed in the 
frequency domain (Sztrymf et al. 2013; Agnoletti et al. 2014). In this procedure the pulse 
wave is Fourier decomposed, and the first 8 harmonics’ amplitudes are compared and 
submitted to correlation tests. The first harmonic corresponds to the heart frequency of the 
analysed pulses, being the remaining harmonics multiples of the first.  
The analysed studies used different statistical approaches to investigate agreement 
between measurements assessed with different techniques, as can be seen on Table 2.4. 
Student t-tests are frequently used to analyse potential significant differences between 
results or different measuring methods. The used confidence interval is typically 95 %, 
reflecting a significance level (p-value) of p < 0.05. As a measure of agreement between 
techniques, Bland-Altman plotting is applied in the majority of the literature references.  
As correlation studies, Pearson’s (PCC) and Intraclass (ICC) correlations coefficients are 
frequently calculated, with common confidence intervals of 95 %. 
Regarding the number of participants, in the analysed literature, it ranged from 12 to 2026 
subjects per study. The invasive validation studies usually include a restrict number of 
subjects due to the difficulties associated with the testing procedures. Therefore, being 
easier to perform, the non-invasive comparison can be carried out in larger cohorts.     
2.6. Conclusion 
In this section, cardiovascular fundamentals on arterial pressure and stiffness were 
introduced. The state-of-the-art of the commercial devices for cSP and AIx assessment as 
well as the usual procedures in their clinical evaluation, were also described. As part of 
the theoretical background of this work, in the next section, the fundamentals on optical 
fibre sensors and their advantages as biomedical monitoring systems, will be discussed.  
                                                                                                                  
Cátia Leitão (2017) 
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Optical fibres are specially known as data transmission systems for telecommunications 
networks. Nevertheless, optical fibres applications are not limited to information transport, 
and may also be used as sensors. A wide range of parameters, such as temperature, 
strain, refractive index, acceleration and humidity, can be monitored using OFS, with 
several advantages over electronic sensors (Grattan and Sun 2000). OFS are generally 
compact and lightweight, can be effectively multiplexed on a single fibre, are immune to 
electromagnetic interference, due to its dielectric nature, and they do not conduct 
electrical current, being safer than electromechanical devices, especially in harsh 
environments and medical facilities (Alberto et al. 2013). There are several types of OFS 
that use the different properties of the propagated optical signal (intensity, phase, 
frequency or spectral contents) to monitor different measurands. In this section, the main 
topics on optical fibre sensors related to the developed work are discussed.  
3 
Fundamentals on optical fibre sensors: 
FBG and intensity based configurations 
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3.1. Principles of light propagation through an optical fibre 
The light propagation through an optical fibre relies on the internal reflections enabled by 
the refractive index transitions between the core and the cladding, accordingly to the total 
internal reflection principle (Ghatak and Thyagarajan 1998). The light interaction between 
core and cladding is governed by the Snell’s law, which states that the reflection of an 
incident electromagnetic wave is related by: 
1 1 2 2n sin = n sin  ,                                            (eq. 3.1) 
in which 1 and 2 are, respectively, the angles of incidence and reflection, and n1 and n2 
are the refractive indices of the interface materials. Applying the Snell’s law to an optical 
fibre, considering ncore and nclad as the core and cladding refraction indices, respectively, it 
can be defined the minimum angle of an incident ray, in the fibre cladding, to occur total 
internal reflection. This angle is known as the critical angle (c) and is given by:  
 
clad
c
core
n
sin
n
  .                                                (eq. 3.2) 
As can be verified in Fig. 3.1, rays with angles lower than c are refracted through the 
cladding. On the other hand, total internal reflection occurs for all rays with angle of 
incidence (i) higher than c. The critical angle also defines the cone of acceptance of an 
optical fibre. 
 
Figure 3.1. Scheme of the total internal reflection conditions and acceptance cone  
(nout - refractive index of the fibre outside; max - maximum angle of a ray entering the fibre 
and t - maximum angle of a transmitted ray through the outside-fibre core interface). 
The fibre numerical aperture (NA) is a dimensionless value that defines the range of 
angles of the incident light accepted by a fibre core, delineating the cone of 
acceptance/emission of the fibre, being defined as: 
2 2sinout max core cladNA= n = n  n  .                          (eq. 3.3) 
i <c
i =c
i >c
max
Core (ncore)
Cladding (nclad)
Fibre
Outside (nout)
t
                                                                                                                  
Cátia Leitão (2017) 
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A specific optical fibre can be monomode/singlemode, as it transmits only the transversal 
mode with negligible mode dispersion, or multimode, which has larger diameter and NA 
(more than 50 µm and 0.2, respectively), allowing the transmission of several other modes 
of the introduced signal. The number of modes transmitted by an optical fibre is 
determined by the V-parameter (V), which depends on the fibre’s radius (fr), the light 
wavelength () and NA, being given by: 
rfV NA
2

 .                                                (eq. 3.4) 
For V smaller than 2.405, a singlemode is propagated through the fibre, otherwise the 
fibre complies the transmission of multimodes. For a step-index profile, the number of 
modes is approximately V2/2 (Ziemann et al. 2008). Monomode fibres, with diameters 
lower than 8 µm and typical NA of 0.11, are therefore better at maintaining the fidelity of 
the optical signals introduced over larger distances than multimode fibres (Keiser 2003). 
This fact is related to the different propagation length of each light ray. For the 
fundamental mode, the propagation length (plength) is given by the fibre length (flength), but 
for all the others rays is defined as: 
length
lenght
t
f
p
cos
 .                                              (eq. 3.5) 
However, for intensity based sensors, in which the transmitted power is related to the 
sensors sensitivity, higher NAs are more important than signal fidelity.  
3.2. Silica and polymeric fibres 
Regarding constituent materials, the used fibres can be of silica or polymeric/plastic 
materials. SOFs have their core and cladding of silica, whereas POFs are typically 
fabricated of poly(methyl 2-methylpropenoate), usually known as poly(methyl 
methacrylate) (PMMA), or other polymers such as amorphous fluorinated polymer, 
polystyrene and polycarbonate (Peters 2011).  
The fibres used in this work were: the PS1250/1500 (FiberCore) for FBG engraving; the 
SMF-28e+ (Corning) as link of the FBG fibre to the data acquisition systems; and the 
GM 4001 (Mitsubishi Rayon Co) for the intensity based sensor. The features of the 
referred optical fibres are presented on Table 3.1.  
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Table 3.1. Features of the SOFs and POF used in this work (data from Kalachev et al. 2005; 
Mitsubishi 2010; Fibercore 2013; and Corning 2014). 
Features PS1250/1500 SMF-28e+ GM 4001 
Core material Silica Silica PMMA 
Operating wavelength (nm) 
1310 
1550 
1310 
1550 
530 
570 
650 
Numerical aperture 0.12 - 0.14 0.14 0.5 
Attenuation (dB/km) 
≈ 10 (1310 nm) 
≈ 120 (1550 nm) 
0.03 (1310 nm) 
0.02 (1550 nm) 
170 (650 nm) 
Core diameter (μm) 6.9 8.2 980 
Cladding Diameter (μm) 125 ± 1 125 ± 0.7 1000 
Coating Diameter (μm) 245 ± 15 242 ± 15 2200 
 
PMMA and Silica, due to the differences in attenuation, have very different operating 
wavelength windows, as can be verified on Fig. 3.2. POF is usually operated in the visible 
and SOF in the infra-red (IR), around 1310 and 1550 nm. 
 
Figure 3.2. Operational windows of PMMA and silica (UV - ultraviolet)  
(adapted from Ziemann et al. 2008). 
The fidelity of signal transmissions through long distances, also due to the signal residual 
attenuation of 1dB/km, made monomode SOF attractive for optical communications. On 
the other hand, in short networks, the 1 mm POF has become popular, even though a 
typical attenuation of 170 dB/km (650 nm) (Peters 2011). POFs great application in 
diverse fields are especially due to their high mechanical resilience. With a Young’s 
module of 3.2 GPa, an elastic module of 10 %, in addition to the flexibility of the large 
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2.2 mm jacket, POFs allow rough handling, such as severe bending and stressing, without 
causing permanent damages. On the other hand SOFs have to be carefully handled since 
they present an elastic limit of 1 - 3 % and a Young’s module of 72 GPa (Peters 2011; 
Bilro et al. 2012; Abrate et al. 2013).  
Other advantage related with POF dimensions are the 980 μm core and the 0.5 NA, which 
allow a certain grade of aligning mismatch in connectorization processes between fibres, 
emitters and receptors. This tolerance avoids the use of the expensive precision tools for 
cleaving and connectorization used for the 125 µm SOFs, since their 8.2 µm core leave 
no margin for possible misalignments (Abrate et al. 2013).  
3.3. FBG and Intensity sensing configurations  
Optical fibre sensing systems are usually composed by four basic components, a light 
source, one or more optical fibres, the sensing element(s), and a photodetector or 
spectrometer. The light source applies the optical signal that is transmitted through the 
optical fibre. The fibre itself can act as a transducer (intrinsic sensor) or only as a mean to 
transmit the signal to and from the transducer (extrinsic sensors). The transducer is the 
light modulator, changing the optical signal features with the measurand, variation that 
can be in amplitude, intensity/optical power, phase, polarization or wavelength/frequency. 
Finally, the optical signal is received in the photodetector/spectrometer. In this section, the 
OFS techniques used in this work for micro displacement monitoring with FBG and 
reflection intensity based sensors, are introduced.   
FBG based sensors 
The first FBG inscribed in a silica fibre was reported in Hill et al. 1978, work developed in 
the Canadian Communication Research Center, Ottawa. The photosensitivity discovery 
was a crucial step for the FBG engraving, and, in 1989, Meltz, Morwy and Glen made 
FBGs writing practical by interferometric means, using UV light at 242 nm (Meltz et al. 
1989). Since then, FBG sensors have been improved and applied as filter in 
telecommunications (André et al. 2001) and as sensors in diverse fields, with great 
importance in structural health monitoring from civil (Antunes et al. 2012) to aerospace 
applications (Kahandawa et al. 2012). In Xiong et al. 1999, the first FBG inscribed in POF 
was reported, being now used as robust and more sensitive FBG solutions for a variety of 
applications (Ye et al. 2009, Marques et al. 2015). 
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FBGs are micro periodical changes of the refractive index engraved in the fibre core. In 
Fig. 3.3 a basic diagram of the working scheme of a uniform FBG, is presented. When a 
broadband light spectrum is injected in the fibre, this optical signal will interact with the 
FBG, where the wavelengths that fulfil its resonation condition are reflected, while the 
others are transmitted. The reflected spectrum is centred at the Bragg’s wavelength (B) 
and in the transmitted signal it can be seen a suppression at the same wavelength 
(Othonos and Kalli 1999). FBGs act essentially as wavelength filters, bandpass in 
reflection and band reject in transmission (Albert 2011). The FBG are highly accurate, 
since wavelength is an unalterable property of the signal along the optical fibres, on 
contrary to, for instance, intensity. Other great advantage of FBG based sensors networks 
are the possibility of engraving several FBGs at the same fibre, allowing multi-point 
monitoring, with only one fibre and one interrogation system. 
 
Figure 3.3. FBG working scheme. 
The Bragg’s wavelength is given by eq. 3.6, where  is the period of the grating and neff is 
the effective refractive index of the guided mode through the FBG.  
2B effn                                                   (eq. 3.6) 
The B dependence on the and neff, turn the FBG sensitive to mechanical (l) and 
temperature (T) variations, accordingly to (Othonos 1997):  
eff eff
B eff eff
n n
n l n T
l l T T
2
     
           
      
.              (eq. 3.7) 
The first term of eq. 3.7 right side represents the strain effect on an FBG, which 
corresponds to a change in the grating spacing and the strain-optic induced change in the 
refractive index. The strain effect (z) may be expressed as: 
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B B e z( p )1     ,                                        (eq. 3.8) 
where pe is the effective strain-optic constant defined by eq. 3.9, where p11 and p12 are 
components of the strain-optic tensor, and  is the Poisson’s ratio. 
2
12 11 12
2
core
e
n
p p ( p p )     .                                 (eq. 3.9) 
For a typical silica optical fibre p11 = 0.113, p12 = 0.252,  = 0.16, and ncore = 1.482, which 
when applied in the above equations, results in an expected FBG (B = 1550 nm) 
sensitivity of 1.2 pm/µ. 
The second term of eq. 3.7 right side represents the temperature effect on the FBG. A 
shift in the Bragg wavelength due to thermal expansion changes the grating spacing and 
the refraction index. This wavelength shift, for a temperature change T, can be 
expressed as in eq. 3.10, where  is the thermal expansion coefficient of the fibre 
(≈ 0.55x10-6 for silica), being given by /T. Whereas , which is equal to n/nT, 
represents the thermo-optic coefficient, being approximately 8.6x10-6 for Germanium 
doped silica fibres. From the referred equation, for an FBG (B = 1550 nm) it is expected a 
temperature sensitivity of 13.7 pm/oC. 
B B( ) T                                            (eq. 3.10) 
The dual sensitivity of the FBGs can represent a problem in knowing if the detect B is 
due to temperature or mechanical variations. To static strain measures, usually an FBG 
sensing approach has to have a second sensor, isolated from mechanical effects, to 
detect temperature variations. For dynamic measures, in which the different strains 
applied to the fibre have much higher frequencies than the temperature changes, the 
latter can be removed by applying high pass filters. Consequently, in this case is not 
necessary the supplementary FBG (Leitão et al. 2013). 
In this work, the used FBGs were inscribed by the phase mask method, as reported by 
Marques 2013, using an UV KrF pulsed excimer laser (BraggStar Industrial-LN, Coherent) 
operating at 248 nm, applying pulses with energy of 5 mJ and repetition rate of 500 Hz.  
The FBGs were used as the sensing element for displacement. In the Fig. 3.4 it can be 
seen a schematic diagram of the FBG reflected spectrum changes due to its compression 
and distension. 
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Figure 3.4. Schematization of the FBG compression and distension effects  
in the reflected spectra.  
Intensity based sensors  
The working principle of intensity fibre sensors (IFSs) rely on the variation of the light 
intensity with a measurand. Such solutions have been reported in several applications, 
such as to detect acceleration (Antunes et al. 2014), turbidity (Keizer et al. 2015) and 
displacement (Orłowska et al. 2015).  
IFSs can be used in intrinsic and extrinsic configurations. The intrinsic intensity sensors 
have several configurations, for instance using interaction with the measurand by micro 
(Rothmaier et al. 2008) and macrobending (Silva et al. 2013), side-polished macrobending 
(Bilro et al. 2011; Jing et al. 2015), or v-shaped insertions on the fibre (Mesquita et al. 
2016).  
As extrinsic approaches, the most known configurations are based on fibre coupling, 
where the applied optical signal leaves the fibre to be modulated by the measurand, 
re-entering the same fibre (reflection configurations) or entering a second fibre(s) 
(transmission configurations). Examples of the referred configurations schemes can be 
seen in Fig. 3.5.  
In the reflection configuration, which is applied in this work, the fibre acts as the emitter of 
the applied signal in the surface to monitor, and receptor of the reflected component. For 
this approach, a 2x1 optical coupler is needed, where the double part ensures the 
transmission of the emitted signal by the optical source, for instance an LED, to the 
second part of the coupler in order to be applied in the reflector. In this approach, the 
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reflected component enter in the same fibre, being then collected to the double part of the 
coupler, and finally captured by the photodetector. In front of the single fibre it should be a 
reflector element, acting as a mirror to the optical signal emitted by the fibre. As the 
measurand moves the reflector, its distance to the fibre tip changes along with the 
intensity of signal collected by the optical fibre, as is schemed in more detail in Fig. 3.6.  
 
Figure 3.5. Schematic examples of IFSs configurations (d, d1 and d2 – different distances). 
 
Figure 3.6. Schematic setup of a reflection configuration using a  
single fibre as emitter and receptor. 
The expected signal intensity variation with the distance between fibre and reflector (d) 
can be calculated. In Fig. 3.7a it can be seen that the distance between the emission cone 
extremities and the fibre centre (h) can be calculated as: 
2 ( )h dtan arcsinNA ,                                      (eq. 3.11) 
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therefore,  
2
2
1
NA
h d
NA


.                                             (eq. 3.12) 
The light cone at the fibre entrance, after travelling 2d in the fibre outside, and considering 
the reflector a 100 % reflective surface, have the same power that the emitted (PE), 
changing only the beam spreading area, and consequently, the collected intensity (IC), 
which, can be given by: 
                   Ec
r
P
I
d.NA
f
NA


 
  
 
2
2
2
1
   
(eq. 3.13) 
 
In the Fig. 3.7b it can be seen that for small distances the behaviour is linear, and is within 
this range that the sensitivity is maximized.  
 
a)                                                                                   b) 
Figure 3.7. Schematization of the collected signal intensity: a) by the fibre, considering the 
reflector as a 100% reflective surface; b) variation with the distance  
between the reflector and fibre. 
In IFSs, is fundamental to potentiate the intensity transmitted through the fibre, and an 
easy way to get high power in these configurations is to use multimode fibres, due to their 
larger cores and cones of acceptance (NAs) than singlemode fibres. The use of such 
fibres, also decrease the cost of IFS solutions for the reasons described earlier. The 
simplicity of this technique in terms of design and interrogation equipment has stimulated 
its application in different fields over the years. The great advantage of such systems is 
obtaining sensitive, robust and low-cost sensors interrogated with simple equipments 
based on LEDs as power sources and PDs to detect the intensity variations. These and 
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other OFS approaches are presently applied in the broad biomedical field, as is discussed 
in the following section. 
3.4. Optical fibre sensors in biomedical applications 
The first great application of optical fibres to medicine had the purpose of illuminate 
internal organs. Together with cameras miniaturization, the introduction of the optical 
fibres was revolutionary for endoscopy (Nezhat 2011). During the past decades, the same 
technology has been adopted to create several biomedical devices for medical treatments 
deliver and as transducers for monitoring parameters of interest for both therapeutic and 
diagnostic purposes (Taffoni et al. 2013). 
OFS are now widely studied and applied in the medical field, for both chemical and 
physical measurands, allying their great features as sensors with the fact of being 
electrically isolated from the patients, which easies the equipments certification process 
for being commercialized as medical devices (ISO 2003). Currently, OFS are used as 
biomedical monitoring solutions in a wide range of applications, whose examples are 
following presented.    
Non-invasive monitoring of vital signals 
In the hospital routine, four vital signals are important to be frequently measured: body 
temperature, respiratory rate, heart frequency and blood pressure. Solutions to monitor 
the respiratory and heart rate have been explored (Silva et al. 2011; Petrovic et al. 2014; 
Chethana et al. 2016), and also as a current trend on OFS, using embedded sensors on 
smart textiles (Grillet et al. 2008, Quandt et al. 2015). Optical fibre solutions are attractive 
for smart medical textiles because they allow both sensing and signal transmission. On 
the other hand, the use of intensity POF sensors allows the development of cheap, 
lightweight, flexible and robust sensors, as they are able to measure high strain values 
without damage. The sensors configurations more reported in smart textiles are with 
FBGs and POF intensity based sensors (Massaroni et al. 2015). 
In the cardiovascular field, some pressure radial waveform monitors had been presented 
using FBGs. In 2005, Van Brakel described a radial bracelet with an optical fibre 
containing two FBGs, forming a Fabry-Perot interferometer, which allowed the registering 
of the arterial pressure wave (Van Brakel et al. 2005). More recently, Sharath et al. 
presented a watch like structure with an FBG to detect the distension movements of the 
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radial artery (Sharath et al. 2014). A FBG method, based on the last device presented, 
was also used to detect the pulse propagation time between carotid and radial arteries 
(Sharath et al. 2015), but the quality of the carotid waves seemed not to be sufficient to 
use it to calculate cSP. The sensors ahead described in this dissertation are a part of this 
research field, allowing to register quality arterial pulses in the carotid artery with the 
purpose of to performing PWA and cSP calculation.  
Minimally invasive monitoring  
OFS have several attractive features to invasive monitoring, such as high flexibility and 
small size of both sensors and cables, allowing their insertion within deep-seated tissues. 
Their accuracy, sensitivity and frequency response (bandwidth of hundreds of kHz) are 
adequate for dynamic temperature, pressure and displacement monitoring applications. 
On the other hand, once more, their immunity to electromagnetic interference allows the 
use of OFS during MRI or computerized tomography guided procedures (Schena et al. 
2016). As examples, fibre optic catheters with tip pressure sensors are currently used in 
intravascular, muscle compartment, intracranial, and intraocular pressure measurements 
(Clausen and Glott 2014). 
OFS have been also applied in minimally invasive thermal treatments for tumour removal, 
for instance by radiofrequency ablation (Yokoyama et al. 2008), high intensity focused 
ultrasound (Wang et al. 2014) and laser ablation (Tosi et al. 2016). Research also have 
been made in the use of optical fibres as in vivo dosimeters used during radiotherapy. The 
small dimensions of OFS based dosimeters, allied with being lightweight and flexible, 
shown that they are minimally invasive and therefore particularly suited to in vivo 
dosimetry. A fibre dosimeter can then be placed directly inside the patient, for example, 
during brachytherapy treatments, as the optical fibres can be placed in the tumour itself, 
or into nearby critical tissues requiring monitoring, through the same applicators or 
needles used for the treatment delivery, providing real-time and in-situ dosimetry 
information (O’Keeffe et al. 2015). 
Another great application of OFS is as force sensors, in minimally invasive surgery, to 
improve tactility by medical operators (Song et al. 2011, Abushagur et al. 2014), in 
procedures, such as vitreoretinal microsurgery (Balicki et al. 2011) and biopsies (Henken 
et al. 2012), as needles shaping sensors. 
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MRI monitoring 
The immunity to electromagnetic interferences turned OFS widely studied solutions to be 
implemented in medical environments with high electromagnetic fields, especially in MRI 
(Alberto et al. 2013). OFS technology is particularly suitable to develop MRI compatible 
sensors, since its immunity to electromagnetic fields contribute to its safety and 
functionalities unalteration. Additionally, the materials of the optical fibres do not perturb 
magnetic fields inside the MRI scanner, which is crucial for the preservation of the imaging 
quality (Taffoni et al. 2013). 
Examples of OFS applications in MRI range from the assessment of needles’ shape, 
deflection and submitted force during imaging guided procedures (Park et al. 2010) to the 
estimation of physiological parameters, such heart and respiratory rates (Narbonneau 
et al. 2008, Jonckheere et al. 2009). 
Biochemical sensing 
Regarding biochemical measurands, OFS sensors are used to detect the presence of 
specific chemical and biological species or monitoring their concentrations (Pospíšilová 
et al. 2015). Several chemical sensors were described to monitor diverse measurands, 
including gases (Grassini et al. 2014) as CO2 (Bao et al. 2013), H2S (Tabassum et al. 
2013), and NH4
+ (Rodríguez et al. 2014), and dissolved ions, as Cu2
+ (Chu and Chuang 
2015) and Zn2
+ (Heng et al. 2016). 
OFS have been also reported in a large number of biosensing applications to monitor 
complex compounds. Recently, a POF surface plasmon resonance sensor for the 
detection of vascular endothelial growth factor (a cancer biomarker) was reported by 
Cennamo et al. 2015. Other compounds were also able to be detected in diverse optical 
fibre techniques, being examples: DNA using optical fibre nano tips coated with molecular 
beacons (Giannetti et al. 2015); estrogen-like molecules and proteins (Wittliff et al. 2008; 
Guo et al. 2016), pathogenic agents recurring to immunosensors (Tawil et al. 2014; 
Srinivasan et al. 2016), and even illicit drugs (Li et al. 2012) and pollutants (Zhong et al. 
2011; Yildirim et al. 2014). The research in detection of biochemical species with OFS 
have been developing a new trending concept, the lab-on-fibre technology, which 
foresees highly functionalized devices integrated into a single optical fibre (Consales et al. 
2012; Cusano et al. 2015; Ricciardi et al. 2015). 
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3.5. Conclusion  
Within the present chapter, the base fundaments of the developed work on OFS were 
exposed. The FBG and intensity sensors configurations were presented, as well as 
several examples of OFS applications in different biomedical areas.  
From the literature research, regarding the optical fibre applications for arterial pulse 
acquisition, no solution was found to enable performing PWA and cSP calculation from 
pulses obtained in the carotid artery. The advantages of the optical fibre sensors in 
biomedical applications, as well as the few developed works studying their application in 
the carotid pulse acquisition, made them a suitable solution to explore. Therefore, the 
present work arises as a new contribution to this field.  
Since this dissertation is organized by the published and submitted papers, whose 
introductions are very similar, in order to not repeat information, this chapter together with 
Chapter 2 embody the introductory concepts of the following chapters. 
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Three optical fibre sensors configurations were developed to meet the main goals of this  
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4.1.  
Feasibility study using fibre Bragg gratings 
 
 
 
 
 
 
 
 
 
 
The implementation and feasibility studies of an FBG based probe, for non-invasive 
monitoring of the carotid pulse, are described in this section. Assessment tests were 
carried out in different volunteers and it was possible to acquire the carotid pulse 
waveform in all subjects. In one of them, the sensor was also tested in terms of 
repeatability. Although further developments will be required for clinical implementation, 
the first studies suggested that the FBG technology can be a valid alternative to the 
commonly used electromechanical tonometers. 
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4.1.1. Sensor assembly and signal detection 
The applied FBG, was engraved through the phase mask technique, in a photosensitive 
singlemode optical fibre (PS1250/1500, FiberCore). It presented a Bragg wavelength of 
1550.20 nm, at room temperature (23 oC), having a 4 mm length.  
The proposed probe, identified as FBGbox, consists in a small outer plastic box (35 × 
35 × 20 mm) crossed by an optical fibre with the FBG positioned in the middle. The fibre 
was pre-tensioned, becoming the Bragg grating sensitive to elongation and compression. 
As presented in Fig. 4.1, a latex membrane was placed between the box and a stainless 
steel sphere (with a diameter of 9 mm), which works as the interface between the FBG 
and the common carotid.  
 
 
Figure 4.1. FBGbox - components drawing. 
During the data acquisition process, the sensor was placed over the carotid artery and the 
obtained signal was monitored in real time. For the sensor interrogation, the signal from a 
C + L broadband optical source (ALS-CL-17-B-FA, Amonics) was launched into the optical 
fibre, being a small spectral band (centred at λB) reflected in the FBG, which is directed by 
an optical circulator to the spectrometer (I-MON 512E-USB, Ibsen), as can be 
schematically observed in Fig. 4.2a. The system presented a maximum acquisition rate of 
970 Hz. The photograph and the probe application in a subject can be seen in Fig. 4.2b 
and c, respectively.  
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a) 
 
b)                                                     c)  
Figure 4.2. FBGbox: a) interrogation system scheme, b) photograph, and  
c) application in a subject. 
4.1.2. Sensor calibration  
The FBGbox was characterized to displacement and its accuracy in pulse wave 
acquisition was also evaluated by applying mechanical synthetized waveforms. The 
system displacement calibration was performed with the controlled vertical movement 
imposed on the sphere. For this task it was used a micrometric translation stage to 
displace the metallic sphere and consequently the Bragg grating. As can be seen on 
Fig. 4.3, the Bragg wavelength dependence with the sphere displacement is described by 
a linear function, with an r2 > 0.99. Considering this result, the pulse waveform assessed 
with the sensor is directly proportional to the Bragg wavelength. The probe showed a 
displacement sensitivity of 2.04 pm/µm. 
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Figure 4.3. Bragg wavelength variation with the vertical sphere movement with linear fitting 
(r
2
 > 0.99; slope = 2.0 × 10
−3
 nm∕μm). 
 
The experimental setup to analyse the sensors response to mechanical waveforms, 
schemed in Fig. 4.4, was composed by a waveform generator (33220A, Agilent 
Technologies), whose produced signals were amplified by a high-voltage piezoelectric 
amplifier (HVPZT) (E-508.00, Physic Instrumente) and applied to an Z/Tilt Piezoelectric 
(PZT) Flexure Stage (P287.70, Physic Instrumente). This specific PZT actuator was 
chosen due to its movement range being close to the carotid distension values, with a 
maximum displacement of 700 μm. For the characterization studies, the sensor was 
placed with the top of the sphere in contact with the moving part of the flexure stage. The 
generated signals were simultaneously monitored with an oscilloscope (TK-220, 
Tektronix). 
 
 
 
Figure 4.4. Sensor characterization setup.  
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For this test, several waveforms were considered, namely the “type-B” and “type-C” 
Murgo’s waveforms. As it can be seen in Fig. 4.5, the FBG sensor detects and follows the 
PZT actuator path, allowing the identification of all characteristic points of the waves, even 
the ones with relatively low amplitude differences. 
  
Figure 4.5. Sensor response to synthetized “type-B” and “type-C” Murgo’s waveforms. 
To measure the accuracy of the sensor response, it was considered the RMSD between 
the PZT applied and FBGbox acquired waves. The obtained results were 7.23 × 10−3 and 
45.14 × 10−3, for the “type-B” and “type-C”, respectively. Although a lower RMSD to 
“type-B” wave was obtained, both values are close to zero, showing an accurate response 
of the sensor in following the actuator motion. These results supported the application of 
this sensor to assess the pulse wave in human carotids. 
4.1.3. Tests in subjects 
The FBGbox was tested in four human carotids of healthy subjects with an average age of 
25 years old (± 2 years), being the subjects identified as I, II, III, IV. For the data 
acquisition, the tonometry standard protocol was used, which consists in detecting the 
carotid pulse by hand and placing the sensor in that location, using the recommendations 
presented in Table 4.1. The recording process started when a steady pulse sequence was 
observed. This acquisition process requires some training for the correct detection of the 
carotid pulse, as does the common process with the state-of-the-art tonometric devices. 
The acquired data, corresponding to the sensor’s Bragg wavelength over time, was 
filtered and normalized in amplitude between 0 and 1. Repeatability tests were carried out 
in one subject (IV) during five days, being the pulse wave assessed in the same day 
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period. In each of these times, at least eight consecutive pulses were recorded and 
analysed. The acquired data were also filtered and normalized between 0 and 1. 
Table 4.1. Recommendations for carotid tonometry (adapted from Van Bortel et al. 2012) 
a) Measurements should be performed in a quiet room with stable room temperature;  
b) Perform measurements in supine position after at least 10 minutes of rest; 
c) Measurements should preferentially be done at the right common carotid; 
d) Because of diurnal variations repeated measurements should be done at the same 
time of the day; 
e) No meal, caffeine or smoking is allowed within 3 hours before measurement; 
f) Speaking and sleeping are not allowed during measurements; 
g) Data should be the mean of registrations during at least one respiratory cycle  
(about 5 - 6 s). 
  
The FBG sensors are sensitive to strain and temperature. In the present application, 
temperature effects resulted in the drifting of the measured signal baseline at very low 
frequencies, whereas the optical noise usually occurs at much higher frequencies. In the 
data processing, it was used a digital filter to minimize both effects, allowing the 
assessment of the arterial pulse wave critical points. For this purpose, it was used a FFT 
bandpass filter (between 0.7 and 50 Hz), and all the results here presented were filtered 
with this method. In Fig. 4.6, raw and filtered data acquired in subject I can be seen. 
These data demonstrate that the applied filter substantially reduces the increasing 
tendency of the signal, which was due to temperature changes in the sensor when placed 
in contact with the skin. At the same type the high frequency optical noise is reduced.  
 
 
 
 
Figure 4.6. Raw and filtered data acquired in the subject I. 
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From the filtered data, the pulses sequences were selected in order to calculate the 
average pulse, for posterior temporal and amplitude analysis. In Fig. 4.7, the pulses 
sequences of the processed data, acquired in the four subjects, are presented. It can be 
seen that for the same subject the wave pattern is similar over time.  
  
  
Figure 4.7. Acquired pulse waveforms in the carotid artery of the four human subjects. The 
top graphs represent the acquired sequences, whereas the bottom charts show the 
overlapping of the pulses and the respective mean pulse (bold). 
All participants had a unique identification curve, presenting different AIx values, 
calculated before the mean pulses normalization between 0 and 1. The subjects I, III, and 
IV presented type-C waves, with values of AIxI = -0.10 ± 0.04, AIxIII = -0.28 ± 0.05, and 
AIxIV = -0.13 ± 0.03. The subject II presented a slightly positive AIxII = 0.04 ± 0.04, having 
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been considered a type-B wave due to the amplitude of the FW and RW peaks being very 
similar. In the Fig. 4.8, the RMSD between each pulse on the sequence and the mean 
pulse can be seen for each subject. Small deviations between pulses of the same 
sequence can be observed with values never reaching a 10 % deviation.  
 
Figure 4.8. RMSD between each sequence pulse and the mean calculated arterial wave, with 
the mean RMSD value represented as the solid line. 
Regarding to the repeatability tests, the analysed pulse wave sequences are presented in 
Fig. 4.9, where each graph represents eight pulses of the acquired signal in each day.  
 
 
Figure 4.9. Acquired data in 5 consecutive days for the subject IV. 
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It can be understood that a low noise pulse wave was detected with a clear distinction of 
the identification points of the carotid pulse wave. The cSP, inflexion and incisura can be 
detailed seen on Fig 4.10a for the mean pulse of the subject IV. The mean AIx for the 
week was -0.19 ± 0.05, value that, as expected, is close to the value earlier assessed for 
the same subject (AIxIV = -0.13 ± 0.05), showing a good repeatability with a maximum 
RMSD of 7 % (Fig. 4.10b). 
 
a)                                                                             b) 
Figure 4.10. Average pulse of five consecutive days: a) pulse wave critical points and 
b) RMSD values of the arterial pulse of each day (dots) to the average pulse of the week, 
with the mean RMSD represented as the solid line. 
4.1.4. Discussion 
This work started with the development of an assembly capable of transferring the carotid 
distending movements to a pre-tensioned optical fibre with a FBG, using a sphere which 
was in contact with the FBG and the carotid artery, transcutaneously.  
The developed probe was characterized to displacement, showing a linear behaviour with 
a displacement sensitivity of 2.04 pm/µm, and an operating range of 280 µm. Concerning 
the response to arterial synthesized waves, applied by the PZT actuator, the sensor 
presented a good agreement with the applied waves, presenting a mean RMSD of 2.6 %. 
Four subjects were studied, and for all of them steady and regular pulse sequences were 
obtained, with a deviation between pulses always lower than 10 %. The quality of the 
acquired pulses allowed PWA, with the identification of the cSP, inflexion and incisura 
points. The obtained AIx values were between -0.28 and 0.04, which was expected for 
young healthy subjects.  
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The repeatability studies were performed in five consecutive days, whose pulse waves 
were acquired in the same period of the day. The mean deviation between the average 
pulses from each day and the weak mean pulse was approximately 5.7 %, which is below 
the maximum deviation allowed by the initial requirements.  
4.1.5. Conclusion 
The high sensitivity of FBGs can impose them as a valuable technology, with the 
advantages offered by the optical fibre technology over the traditional sensors. In this 
section, it was reported the initial study performed with a FBG based OFS to acquire the 
carotid pulse wave.  
This work delivered promising results in the application of the FBG technology in the pulse 
wave acquisition, and the developed sensor seems to be a valid alternative to 
electromechanical tonometer. Besides the good results, the FBGbox testing showed that 
its user friendliness could be improved, and therefore a second FBG based approach was 
developed with a pen-like shape (FBGpen). Details of this probe design, characterization 
and performance, are presented in the following section. 
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4.2.  
Portable pen-like probe based on  
fibre Bragg gratings 
 
 
 
 
 
 
 
 
 
 
In this section, a second version of the FBG based probe is presented. This probe has a 
pen-like shape, facilitating its application on the carotid artery. The sensor was 
characterized and its response to controlled waveforms was studied. Finally, tests were 
performed on human subjects. The developed sensor has a displacement sensitivity of 
21.20 pm/μm, and showed its ability to detect the carotid pulse wave transcutaneously in 
the neck surface.  
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4.2.1. Sensor assembly and signal detection 
The proposed sensor uses a FBG, engraved in a photosensitive optical fibre 
(PS1250/1500, FiberCore) by the same method reported in section 4.1.1, with a Bragg 
wavelength of 1547.10 nm at room temperature (23 oC). The probe’s body consists of an 
aluminium tube (diameter = 1 cm) crossed by the optical fibre with the FBG, as schemed 
and photographed in Fig. 4.11. The fibre is fixed in points A and B, with the FBG 
positioned in the middle of these points. Point A is located at the probe movable interface, 
which is maintained in extension by a metallic spring. To improve the sensor stability 
when monitoring the carotid pulse, it was implemented a stabilization cover, as showed in 
the referred figure. In this work, this probe is identified as FBGpen. 
 
Figure 4.11. FBGpen technical drawing and photographs. 
The assembly process begins with the insertion of the fibre through the tube extremity, 
after what the bare fibre is glued with epoxy to point B, which is left curing for 1 day. At the 
top of the tube is inserted the polymeric interface that is pushed from the exterior in, with 
the spring at its minimum longitudinal position, as the extremity of the fibre is glued to it. 
After curing during another day the interface is left free and the spring pullet out, 
stretching the optical fibre. When the sensor’s movable interface is placed in contact with 
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the carotid artery, its distension movements cause the interface movement and 
consequent FBG deformation.  
Changes were made in the data acquisition setup, concerning the one presented in the 
subsection 4.1.2., in order to improve portability and autonomy. The new FBG data 
acquisition system is composed by a C band light source module (AS4500, B&A 
Technology), a circulator (6015-3, Thorlabs), the spectrometer (I-MON 512E-USB, Ibsen), 
and a rechargeable battery (8000mAH, LC-Power), as can be schematically observed on 
Fig. 4.12a. The data can be acquired using a computer, or in the present case, a tablet 
(see Fig. 4.12b). The use of the tablet and the rechargeable battery highly improved the 
portability and autonomy of the system, as the acquisition system has now around eight to 
ten hours of autonomy.  
 
                  a)                                                                    b) 
Figure 4.12. FBGpen data acquisition system a) scheme and b) photograph. 
4.2.2. Sensor calibration  
The sensor calibration to displacement was performed in the same experimental setup of 
FBGbox in order to attain Bragg wavelength dynamic range and sensitivity. In furtherance 
of assessing the probe’s accuracy, the response to synthetized Murgo’s mechanical 
waveforms was also studied. 
The probe presented a linear behaviour between 1546.60 and 1547.02 nm, for a total 
Bragg wavelength variation of 420 pm. From the linear fit between the measured Bragg 
wavelength and the interface movement, a sensitivity of 21.20 ± 0.04 pm/μm was 
reached, as can be seen on Fig 4.13. The stabilization cover, showed in Fig. 4.11, has 
also the function of to limit the interface movement within the region with linear behaviour 
and higher sensitivity.  
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Figure 4.13. Bragg wavelength variation with the interface displacement with linear fitting 
(r
2
 = 0.99, slope = 21.20 ± 0.04 pm/µm).  
As presented in Fig. 4.14, the sensor showed the capacity to resolve two similar 
waveforms. In this test, the sensor accuracy was once more assessed by calculation of 
the RMSD, wherein the obtained mean values was 0.06. 
 
 
Figure. 4.14. Sensor response to synthetized pulse waveforms. 
4.2.3. Tests in subjects 
Human testing was carried out following the standard tonometry protocol. In Fig. 4.15, the 
sensor application in one of the subjects can be seen. The raw data assessed with the 
sensor usually shows oscillations due to respiratory movements, temperature effects on 
FBG and some artefacts due to operator movements, which were removed from the 
original signal by digital filtering, as presented in section 4.1.3.  
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Figure 4.15. Arterial pulse wave acquisition in the carotid artery. 
The central pulse pressure waves from four healthy subjects, with ages between 16 and 
35 years, are showed in Fig. 4.16, where it can be seen that all subjects presented their 
unique wave pattern.  
 
Figure 4.16. Arterial pulse waves detected in four human subjects. 
In Fig. 4.17 are presented the detailed pressure waves acquired in a 16 year-old male 
(Subject I) and a 28 year-old female (Subject IV), as well as the respective frequency 
components, which are almost null after 15 Hz. This result is expected, since the 
physiological pressure in humans has its largest components below 14 Hz (Nichols 1990). 
It can also be verified the arterial pulse critical points components: cSP, inflection and 
incisura. The Subject I presented an AIx of -0.472 and the Subject IV -0.172. 
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Figure 4.17. Arterial pulse waves, of subjects I and IV, in time and frequency domains. 
The AIx values are negative, and therefore accordingly to Murgo’s classification both 
waves are type-C waves. Once more, expected for two healthy young subjects.  
 
4.2.4. Discussion 
In this work a new pen-like probe using an FBG to monitor the arterial pulse was 
proposed. A new interrogation approach was also developed in order to improve 
portability and autonomy of the data acquisition system. FBGpen presented a sensitivity of 
21.20 ± 0.04 pm/µm, corresponding to ten times the value obtained with FBGbox, 
sacrificing however the sensor dynamic range, which become around 16 µm. The 
accuracy tests showed a RMSD of approximately 6% and the tests in subjects 
demonstrated its capability of successfully detect the central arterial pulse.  
Detailed pulse wave analysis was performed for two subjects, one male with 16 years-old 
and a female with 28 years-old. It can be seen an accentuated difference in the amplitude 
of the first two harmonics, due to difference in the reflection wave arrival time and 
amplitude. As can be noted in the Fig. 4.18, with the natural arterial stiffening effect, the 
major reflection components began to arrive earlier in systole, increasing the AIx and the 
pressure load in the left ventricle.  Since the individuals are both young and healthy, they 
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have negative AIx, presenting “type-C” waves, but the normal effects of aging are well 
denoted in the pulse wave morphologies of these subjects with 12 years of age difference.  
 
Figure 4.18. Arterial pulse wave morphologies of Subject I (16 years old) and  
Subject IV (28 years old). 
4.2.5. Conclusion 
A high sensitivity was achieved with this new approach. The sensor response was in good 
agreement with the controlled imposed waveforms. It was also possible to obtain the 
pulse waveforms in the studied four volunteers, each one having their own pulse wave 
morphology. Two subject’s waveforms were studied in time and frequency domain, which 
clearly showed the effects of normal arterial stiffness effects with aging.  
This work delivered more promising results for the application of FBG technology in the 
pulse wave acquisition. However, besides the development of new reliable sensors to 
arterial pulse assessment, a second goal of this dissertation was to produce low cost 
solutions. Even though the systems for FBG interrogation have been decreasing in price, 
they are still a relatively expensive technology, which could delay its introduction in the 
general clinic market, which need reliable and low cost solutions. To surpass this FBG 
limitation, an intensity based pen-like POF approach was also explored, and the results 
are presented in the next section.  
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4.3.  
Cost-effective intensity based sensor  
 
 
 
 
 
 
 
 
 
 
 
In this section, an intensity based plastic OFS for non-invasive monitoring of the carotid 
pulse waveform is presented. The advantages of this sensing method are the low 
implementation cost, high robustness, and signal processing simplicity. At this work stage, 
it was also developed an automated interface for data processing. As preliminary proof of 
concept, the sensor was used to detect the arterial pulse waveform in some human 
subjects, allowing the assessment of central pressure. 
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4.3.1. Sensor assembly  
The first version of the intensity based probe, named POFpen, comprised a cylindrical 
support, holding a PMMA POF (GM 4001, Mitsubishi Rayon Co) at the centred position, 
3 mm spaced out from the sensor end surface, as schemed in Fig. 4.19.  
 
 
Figure 4.19. Schematic drawings and photography of the first version of POFpen. 
After some preliminary testing, the support of the POF was improved to a 3D printed 
polylactide pen, schematically presented in Fig. 4.20a. Along this section, both versions 
appear, regarding different work stages.  
 
a)                                                              b) 
Figure 4.20. Schematic drawing of: a) the POFpen’s latest version and b) application on the 
carotid’s reflector. 
The sensor operates in reflection, using a 2x1 coupler (P/N IF-562, Industrial fiber optics), 
a red LED source (IF-E96, Industrial fiber optics) and a photodiode (IF-D91, Industrial 
fiber optics), being its system schemed in Fig. 4.21. For the pulse acquisition, it is 
launched an optical signal in the fibre from the LED source. Once out of the fibre, the 
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signal is reflected in the adhesive taped on the neck (above the carotid artery), returning 
to the fibre, reaching the photodetector. The micro distension movements of the carotid 
change the distance between the reflector and the fibre, modulating the reflected light. 
This sensing approach can allow to assess the pulse waveform without pressing the 
artery in the way needed for arterial tonometry.  
 
Figure 4.21. POFpen acquisition system scheme and interrogator photograph. 
 
The interrogator uses a microcontroller (PIC24FJ256DA206, Microchip Technologies), 
with a 16-bit ADC, which operates in a full-scale voltage of 2.5 V, resulting in a resolution 
of 38.15 µV. The interrogation module is remotely controlled in the computer by a 
LabVIEW® customized application using Bluetooth®, allowing the real-time monitoring and 
saving of the assessed data. The system is powered by a battery that provides an 
autonomy higher than 24 hours.  
 
4.3.2. Calibration 
The calibration to displacement was performed using the same experimental approach 
earlier presented. The sensor exhibited a linear behaviour, with a dynamic range of 
295 µm, being the measured signal amplitude, as function of the reflector displacement, 
1x2 Optical
coupler
Interrogation system
LED
LED beam
Reflector
Probe
Skin
Artery
Arterial 
distension
movements
Battery
Bluetooth 
module
PDsLEDs
SD Card and 
microcontroller 
On/Off 
button
Front view
Inside view
Back view
Tablet/PC
POF
PD
 
Optical fibre sensors as a non-invasive technology to the central arterial pressure assessment 
 
74 
 
presented in Fig. 4.22. From the linear data fitting, a sensitivity of 727 ± 10 μV/μm was 
attained, with a determination coefficient of r2 = 0.99. 
 
Figure 4.22. Sensor response to displacement with linear fitting 
(r
2
 = 0.99; slope = 727 ± 10 µV/µm). 
4.3.3. Data processing interface 
In this section the developed algorithm for fast and easy processing of the pulse wave 
data is presented. The Labview® application, used to control the data acquisition system, 
creates “*.txt” files after each acquisition, which can be loaded in the developed Matlab® 
graphical user interface (GUI), presented in Fig. 4.23.  
The pulse wave is a periodic signal with a steady component, corresponding to the 
diastolic pressure. It also usually complies very low frequency noise related with intrinsic 
factors to the patient and operator, such as respiratory and small involuntary movements. 
In the GUI, any pulse sequence “.txt” file can be loaded in order to proceed to its filtering, 
calculation of the average pulse, PWA and cSP calculation.  
After the file loading, the data is graphed for the operator to select the data sequence to 
be segmented into individual pulses for subsequent overlapping and calculation of the 
average pulse. For an accurate segmentation, precise calculation of the “cutting” point of 
the pulses is essential. In this work, the pulses segmentation is performed by the points of 
the data sequence where the 2nd derivative is maximum, as showed in Fig. 4.24, a 
recognized method by the field’s experts (Laurent et al. 2006). 
After segmentation, the pulses are normalized between 0 and 1, and finally superimposed 
to determine the average pulse, from which are calculated: systolic peak, inflexion, 
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incisura, tsystole, tdiastole, FF (MAP point of the central arterial wave). After introduction of the 
brachial pressure levels, the cSP is calculated. 
 
Figure 4.23. GUI developed in Matlab® - steps to the calculation of the average pulse, critical 
points, AIx and cSP. 
The determination of the pulse wave critical points starts with the identification of the cSP 
peak, which corresponds to the absolute maximum of the average pulse. The other critical 
points are determined by analysing the 2nd derivative, whose peaks allow the 
determination of the inflexion point and incisura, as can be observed in Fig. 4.24. 
 
Figure 4.24. Use of the 2
nd
 derivative to identify the inflexion and incisura 
(subject’s heart rate - 60 bpm). 
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First the incisura is determined, corresponding to the 2nd derivative maximum between 20 
and 50% of the wave. After that, the maximum of the 2nd derivative between the wave foot 
and incisura is found, matching the inflexion. 
To ascertain if the cSP corresponds to FW or RW, it is determined whether the inflection 
point occurs before or after the cSP point. The FF corresponds to the arithmetical average 
of all pulse wave points. Concerning the time parameters, tsystole matches to the incisura 
index and tdiastole corresponds to the subtraction of tsystole to the total pulse duration.  
4.3.4. Tests in subjects 
As preliminary proof of concept, similarly to the past sections, the sensor was used to 
detect the arterial pulse waveform in human subjects. Once more the data acquisition 
followed the tonometry protocol and clinical recommendations. The carotid artery was 
found by palpation, and where the heart beat was more strongly felt, it was placed the 
reflective adhesive, as can be observed in Fig. 4.25.  
 
Figure 4.25. Sensor placement in the measuring location (with the reflective adhesive 
attached above the carotid artery). 
The acquisitions were performed in four healthy subjects, denominated MN29 (male, 25 
years old), SN21 (female, 28 years old), MS02 (female, 31 years old) and CL13 (female, 
30 years old). Segments and overlapping of the pulses can be observed in Fig. 4.26, for 
the four subjects. It can be perceived that the superimposed pulses are very similar to 
each other, showing that the sensor has good stability, repeatability and ability to assess 
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the pulse wave. Subject MS02 presents the most unstable pulse segment due to a more 
profound respiration, which modulated the pulse wave signal. However, after 
normalization and overlapping this modulation is negligible. 
 
a)                                                                      b) 
Figure 4.26. Pulses a) sequence of acquired in each subject and b) overlapping for average 
pulse calculation. 
As the pulses are normalized, the FF is a point between 1 and 0. Matching MAP to FF and 
DP to the wave foot, is performed the pressure calibration. The pressure values and FF of 
each subject are represented in Table 4.2. After calibration, the assessed central pressure 
profiles can be seen on Fig. 4.27. 
Table 4.2. Brachial pressures, MAP, FF and cSP values. 
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Figure 4.27. Calibrated pressure waves for the four studied subjects  
(the horizontal line represents MAP). 
It can be verified that the cSP values do not correspond to a direct inference of the 
brachial blood pressure, and subjects with very similar brachial pSP, such as MN29 
(110 mmHg) and SN21 (112 mmHg), can have very different cSP, 94 mmHg and 
101 mmHg, respectively.  
Repeatability study 
Acquisitions were performed in 5 healthy subjects whose anthropometric data are 
presented on Table 4.3. These measures had the goal of testing the same subject at the 
same conditions, in different days and periods. Two measurements per day, one at the 
morning period and the other in the afternoon, were performed during a week using the 
exam procedure reported before.  
Table 4.3. Anthropometric and family history data of the analysed subjects. 
Subject Gender 
Age 
(years) 
Weight 
(Kg) 
Height 
(m) 
Cardiovascular 
problems in the 
family 
1 Male 25 65 1.73 No 
2 Female 28 58 1.60 No 
3 Female 32 58 1.60 No 
4 Female 31 64 1.66 Yes 
5 Female 30 63 1.64 Yes 
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From the acquired data sequences, for each morning and afternoon periods, an average 
pulse was calculated. For each subject, it was also calculated the average pulse for the 
mornings and afternoons of the all week. The RMSD was assessed by comparing each 
pulse with the week average pulse for each period, being the results presented in 
Tables 4.4 and 4.5, for morning (M) and afternoon (A), respectively. As can be seen on 
both tables, RMSD values are very low and in accordance with the application 
requirements, showing that the sensor is reliable, maintaining a constant response 
throughout the days.  
Table 4.4. RMSD values between the morning pulses and the week average morning pulse 
(Mn – ‘n’ stands for the day of the week, starting on Monday, and AM represents average 
morning pulse of all week). 
Subject M1/AM M2/AM M3/AM M4/AM M5/AM 
Average 
RMSD 
1 0.057 0.034 0.055 0.070 0.070 0.057 
2 0.029 0.072 0.038 0.018 0.031 0.038 
3 0.026 0.038 0.020 0.021 0.056 0.032 
4 0.031 0.060 0.030 0.131 0.023 0.056 
5 0.063 0.033 0.074 0.029 0.040 0.048 
 
Table 4.5. RMSD values between the afternoon pulses and the week average afternoon 
pulse (An –‘n’ stands for the day of the week, starting on Monday, and AA represents 
average afternoon pulse of all week). 
Subject A1/AA A2/AA A3/AA A4/AA A5/AA 
Average 
RMSD 
1 0.032 0.026 0.032 0.067 0.087 0.049 
2 0.032 0.047 0.015 0.047 0.032 0.035 
3 0.030 0.021 0.022 0.031 0.013 0.023 
4 0.137 0.023 0.070 0.035 0.054 0.064 
5 0.031 0.066 0.034 0.044 0.020 0.039 
 
In Fig. 4.28, the superimposition of the mean morning and afternoon pulses of each 
subject is represented. It can be seen that the wave morphologies change little from 
morning to afternoon, being the main differences in HR, with some subjects having higher 
HR (low pulse duration) at the morning and others at the afternoon. It can be also verified 
that the small differences in HR had more impact in the diastolic than the systolic duration. 
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Figure 4.28. Comparison of the average pulses of morning and afternoon for each subject. 
Study of the central arterial pressure before and after exercise 
In order to test the sensor for the same subject at different HR conditions, a volunteer was 
subjected to a test to evaluate central pressure in the resting position, followed by 5 
minutes of running, after stopping for 2 minutes and 4 minutes. The Fig. 4.29 shows the 
central pulse shape and respective pressure values, being possible to see the changes 
from the resting (R) position, to immediately (AE), 2 (AE2) and 4 (AE4) minutes after 
exercising. 
It can be seen that the central pulse wave changes in morphology and pressure between 
the different conditions. A notable change is the almost disappearance of the dicrotic 
wave, which is the slight pressure increasing usually seen after the incisura. Nevertheless 
in the situation AE4, it can be denoted the start of the dicrotic wave resurging.  
With regards to SP values, as presented on Table 4.5, both peripheral and central 
pressures rise after the running, to which follows pressure recover to the basal values. It 
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can also be verified that 4 minutes after exercise, despite the pSP being lower than the 
resting values, the cSP still not recovered to its basal value. 
 
Figure 4.29. Mean arterial central pressure profiles of subject 1 in the different situations, 
after and before running.  
Table 4.5. pSP, DP and resulting cSP, for four different HRs.  
State 
HR 
(bpm) 
pSP 
(mmHg) 
DP 
(mmHg) 
cSP 
(mmHg) 
R 67 111 66 96 
AE 112 126 68 110 
AE2 101 116 63 105 
AE4 86 108 65 99 
 
4.3.5. Discussion 
In this section it was presented a simple and low cost intensity based POF sensor for 
pulse waveform monitoring. The probe presented a sensitivity of 727 ± 10 µV/µm, for a 
dynamic range of 295 µm. The device was tested in four volunteers to assess cSP. To 
accomplish this goal, the pulses were segmented and overlapped to calculate the average 
pulse, which was calibrated to pressure using brachial DP and MAP values. In the data 
analysis, it was verified two subjects, with very similar pSP values, presenting significantly 
different cSP.  
The second step was testing the probe’s repeatability, for which 5 subjects were recruited 
to preform measures during 5 consecutive days. The RMSD values between the day 
periods, morning and afternoon, were calculated for all the subjects, in which the 
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maximum values were around 6 % for both periods, below the maximum accepted 
deviation for pulses assessed in the same subject (10 %). 
Finally, the probe was tested in a subject before and after physical exercise. Right after 
running, both pSP and cSP increased. After 4 minutes, the pSP had been re-established 
to its resting value, which not happened to the cSP that was still higher than in the 
beginning. This test stressed once again that the pSP lowering is not necessarily 
translated into the exactly same behaviour of cSP. 
4.3.6. Conclusion 
The preliminary proof of concept showed that the sensor can be used to monitor pulse 
waveform and the cardiac rhythm. With the proposed arrangement, the POFpen and 
interrogation unit reached a sensitivity suitable for arterial pulse wave assessment. The 
preliminary testing presented promising results in the use of POFpen for cSP assessment. 
Its low fabrication costs allied to the good stability and accuracy in detecting the arterial 
pulses, turned POFpen the chosen sensor to perform pre-clinical analysis, which is 
presented in the next chapter.    
 
 
83 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Distension waves have already been used, and may be preferable to pressure, to perform 
PWA and cSP monitoring, due to the non-necessity of artery applanation (Hirata et al. 
2006). In this chapter results are presented in the evaluation of the accuracy of cSP 
estimation with POFpen, having as reference regular arterial tonometry. This study had as 
main goal to ascertain the viability of presenting POFpen for clinical evaluation procedures 
in broader cohorts, being for that reason referred to as pre-clinical study. For that purpose, 
carotid distension and pressure waveforms were acquired in 15 young subjects. FF%, 
RMSD, harmonic decomposition and central systolic pressures obtained with both 
techniques were analysed. The strong PCC, found between techniques in cSP 
assessment, supported future clinical evaluation studies in larger cohorts. 
5 
Pre-clinical evaluation 
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5.1. Materials and methods 
Within this pre-clinical study, 15 subjects with ages between 22 and 34 years old, were 
recruited. After giving their informed consent, in each one, the carotid pulses were 
acquired with the two probes, POFpen and Complior Analyse®.  
POFpen and Complior have the same clinical exam procedure, following the tonometry 
recommendations. The acquisition process began with the subject in supine position 
followed by a short cardiovascular risk questionnaire. The patient rested for about 10 
minutes before the data acquisition, which usually took no more than 2 minutes. The 
brachial blood pressure was assessed before and after each measure to confirm 
haemodynamic stability, using a commercial pressure cuff (M6 Comfort, OMRON). 
POFpen and Complior cannot be used simultaneously, as in each patient there is usually 
only one optimal location for pulse waveform acquisition, so the measurements were 
performed consecutively. The pulses acquired with both techniques were calibrated with 
the same brachial MAP and DP values, assessed between both acquisitions.  
Curves from the two devices were superimposed in time domain, as carried out in similar 
studies (Sztrymf et al. 2013; Agnoletti et al. 2014), for FF% and RMSD calculation. To 
analyse the frequency components of the waves assessed with both techniques, Fourier 
decomposition was performed, after which the amplitudes of each harmonic (until the 8th) 
were compared. The difference between techniques was statistically analysed by paired 
student’s t-tests, Pearson correlation and Bland-Atman analysis. Two-tailed values of 
p < 0.05 were considered statistically significant. The statistical calculations were 
performed with IBM SPSS Statistics 23. 
5.2. Results  
The characteristics of the 15 volunteers of the study as well as the brachial arterial 
pressures used to calibrate the arterial pulses, are represented in Table 5.1. All the 
patients were healthy and only one had recent hypertension diagnosis, which was treated 
and under control, with normal pressure values.  
After data processing, and pulses normalization between 0 and 1, the acquired pulses 
with both techniques were superimposed for comparison, as the examples showed in 
Fig. 5.1. A first assertion is that POFpen waves, even though presenting similar 
morphology, tend to have a higher curve integral than pressure waves. 
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Table 5.1 Characteristics of the volunteers and brachial pressure values  
assessed through the acquisition process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. Superimposed waves acquired by POFpen and Complior in two subjects. 
As can be seen in Table 5.2, the difference between curves is more pronounced during 
diastole (RMSD = 0.15 ± 0.03 a. u.) than during systole (RMSD = 0.09 ± 0.03 a. u.), 
resulting in a mean RMSD of 0.14 ± 0.02 a. u..  
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Variables Quantity 
Male gender, nsub (%) 5 (33.3) 
Age, y ± SD 29.2 ± 3.6 
Weight, kg ± SD 63.9 ± 13.1 
Height, m ± SD 1.66 ± 0.10 
BMI, kg/m
2 
± SD 22.99 ± 2.43 
Hypertensives, nsub (%) 1 (6.7) 
Anti-hypertensive treatment, nsub (%) 1 (6.7) 
Cardiovascular family history: 
None, nsub (%) 
Hypertension without events, nsub (%) 
Hypertension with events, nsub (%) 
 
3 (20) 
5 (33) 
7 (47) 
Cholesterol: 
Normal, nsub (%) 
Borderline, nsub (%) 
 
11 (73) 
4 (27) 
Smoking habits: 
Never smoked, nsub (%) 
Ex-smoker (> 1 y), nsub (%) 
 
13 (81) 
2 (19) 
Arterial blood pressure: 
Systolic pressure (mmHg ± SD) 
Diastolic pressure (mmHg ± SD) 
Mean arterial pressure (mmHg ± SD) 
 
106 ± 11 
62 ± 7 
77 ± 7 
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Table 5.2. Form factor, RMSD, harmonics amplitudes and cSP results for both techniques. 
Variables POFpen Complior 
RMSD (a. u. ± SD) 
Systolic RMSD (a. u. ± SD) 
Diastolic RMSD (a. u. ± SD) 
0.14 ± 0.02 
0.09 ± 0.03 
0.15 ± 0.03 
Form Factor (%) 51.1 ± 5.2 41.5 ± 5.7 
Harmonics amplitude (a. u. ± SD) 
1
st
 Harmonic 
2
nd
 Harmonic 
3
rd
 Harmonic 
4
th
 Harmonic 
5
th
 Harmonic 
6
th
 Harmonic 
7
th
 Harmonic 
8
th
 Harmonic 
 
0.360 ± 0.031 
0.182 ± 0.027 
0.089 ± 0.028 
0.049 ± 0.014 
0.049 ± 0.012 
0.029 ± 0.012 
0.020 ± 0.007 
0.015 ± 0.004 
 
0.373 ± 0.061 
0.183 ± 0.035 
0.095 ± 0.026 
0.060 ± 0.017 
0.054 ± 0.014 
0.034 ± 0.015 
0.025 ± 0.013 
0.022 ± 0.006 
cSP (mmHg ± SD) 96.6 ± 13.0* 96.0 ± 11.9 
                        *values after FF% correction 
 
Even though the assessed distension waves presented higher FF% values, a linear 
relation between both sensors results, with a slope of 1.01 ± 0.13 a. u., was verified, as 
presented in Fig. 5.2a. The corresponding Bland-Altman plot, in Fig. 5.2b, shows a mean 
FF% difference of approximately 10 ± 2 %. This value is used to correct POFpen FF% 
before cSP calculation. 
 
 
a)                                                            b) 
Figure 5.2. Relation between the FF% of distension and pressure waves: a) dispersion plot 
with linear fit (PCC= 0.91 (p < 0.001), slope = 1.01 ± 0.13 a. u.) and b) Bland-Altman plot. 
 
Concerning the frequency components, in Table 5.2 it can be seen that the highest 
difference between both probes is 0.013 a. u., verified for the 1st harmonic, being all the 
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other variations below this value. The mean harmonics amplitudes for each device are 
graphically represented in Fig. 5.3. Paired t-tests had shown that the first four harmonics 
are not significant different between them (p < 0.05), and Pearson correlation studies 
revealed that the 2nd - 7th harmonics are correlated (p < 0.05).  
 
Figure 5.3. Fourier decomposition of the waveforms for POFpen and Complior - average 
amplitude of each harmonic with respective SD. 
To calculate cSP with POFpen, the pulses FF% was corrected using the 10 % mean 
difference reported earlier. The results, presented in Table 5.2, are very similar between 
techniques and, as can be seen in Fig. 5.4a, both assessed pressures have a linear 
proportionality between them, with a PCC of 0.99 (p < 0.001).  
 
a)                     b) 
Figure 5.4. Adjusted cSP obtained by POFpen and Complior: a) dispersion plot with linear fit 
(PCC = 0.99 (p < 0.001), slope = 1.07 ± 0.05 a. u.) and b) Bland-Altman plot. 
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The Bland-Altman analysis of Fig. 5.4b shows that almost all the results are within the 
confidence interval as well as a POFpen slight underestimation of cSP in 0.6 ± 2.4 mmHg. 
5.3. Discussion 
The present study had the aim of to assess the POFpen accuracy before its introduction 
in broader clinical trials, using as reference the most recent version of Complior, the 
Complior Analyse®.  
Some studies on Complior Analyse validation were found in the literature. In 2013, 
Sztrymf et al. reported a small study with 12 patients, comparing Complior’s signals with 
invasive aortic pressure data, showing that there was no statistical difference in the 
amplitude of the harmonics between both signals and the form factor differences between 
techniques were 4.2 ± 2.8 %. Pereira et al. reported another invasive study, with 15 
patients, comparing pulses obtained by Complior and invasive aortic pressure 
assessment, resulting in a Complior underestimation of cSP of 1.80 ± 4.20 mmHg (Pereira 
et al. 2014). Finally, Stea et al. performed the comparison of Complior Analyse with 
SphygmoCor, which is the most used arterial tonometer worldwide. In this study, involving 
120 patients, a cSP difference of -0.7 ± 5.6 mmHg between both techniques was 
detected, concluding that Complior Analyse can be interchanged with SphygmoCor (Stea 
et al. 2014). The presented data supported the use of Complior to preliminarily validate 
POFpen.  
In this work, results from a 15 subjects’ cohort were analysed, starting with the study of 
RMSD between POFpen and Complior acquired waves, considering the latter as the 
reference device. A mean RMSD of 0.14 was achieved, deviation that was considered 
admissible, due to the expected differences related to their unalike nature (distension and 
pressure). FF% was also evaluated, had been verified a difference of 10 %, very close to 
the results achieved by Kips et al., which reported the comparison of pressure waves 
acquired with SphygmoCor® with distension waves assessed by Echotracking, obtaining 
a FF% difference of around 6 %. These identified variations between distension and 
pressure waves derive from the viscoelastic properties of the arterial walls.  
The pulse waves were also analysed in the frequency domain by performing Fourier 
decomposition of the signal, similarly to other studies (Sztrymf et al. 2013; Agnoletti et al. 
2014), were the amplitudes of the first 8 harmonics were compared. All the harmonics 
presented similar amplitude, never differ more than 0.013 a.u..  
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Finally cSP was compared for both techniques. Given the FF% reported mean difference 
of 10 ± 2 %, from all the POFpen assessed waves, FF% were subtracted 10 % to 
calculate cSP. After that correction, the cSP difference between techniques was 
0.6 ± 2.4 mmHg, in the range of the difference between Complior and SphygmoCor 
reported by Stea et al. 2014. 
5.4. Study limitations 
Nevertheless the consistency of the presented results, some limitations should be 
addressed and taken in consideration when interpreting the data, especially the small 
cohort, with subjects within the same age range and low BMI. Other limitation was the 
non-random order of the acquisitions, the POFpen was always used after the Complior 
device. Since it was a preliminary test, in a small cohort, it was chosen to standardize the 
procedure in all the acquisitions. Nevertheless the study limitations, the results were 
praiseworthy in to fundament the POFpen final evaluation through clinical studies. 
5.5. Conclusions 
In this work, POFpen and Complior acquired carotid waves were compared to analyse the 
ability of obtain the central pressure from the distension waves. It was observed that 
POFpen assessed pulses had a higher FF% than the reference. Regarding cSP, a strong 
linear correlation between central pressures calculated with both curves was found, 
showing the possibility of to obtain central pressure from distension waves. These results 
support the application of POFpen in future clinical studies. 
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In this section, it is presented data from the non-invasive clinical evaluation of POFpen, 
using a commercial piezoelectric device, Complior Analyse®, as reference technique. 76 
patients with ages between 20 and 80 years old entered the study.  The pulses from all 
the subjects were superimposed to calculate the deviation of the pulse wave morphology 
between techniques. AIx% and cSP values were compared using intraclass correlation 
and Bland-Altman plots. Strong correlations were found between techniques, showing that 
the POFpen can measure pulse waves accurately, allowing to assess the AIx% and cSP.  
6 
Non-invasive clinical evaluation 
 
: 
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6.1. Materials and methods 
A total of 81 patients, with prescribed PWV and cSP with Complior Analyse®, were 
recruited from the HT consultation of the CHBV (Aveiro, Portugal). The exclusion criteria 
were arrhythmia, premature ventricular beats, respiratory problems, movement artefacts 
and severe mental problems. After the criteria application, 76 patients were suitable 
candidates for the study, which was approved by the local ethics committee. 
The exams were carried out by two experienced technicians, in 10 different random days 
during a period of 5 months. POFpen testing was always performed after the prescribed 
cSP and PWV exams, in order to not influence the regular exam routine. The brachial BP 
values were evaluated before, in between and after both devices acquisitions to assess 
haemodynamic stability, using the sphygmomanometer M6 Comfort from OMRON. 
Nevertheless, the used BP values to calibrate the pulses acquired with both techniques 
were the ones taken between the two measurements. 
The pulses assessed with both devices were superimposed for all subjects, and were 
analysed by RMSD, FF%, 8 first harmonics amplitude, AIx% and cSP, being all values 
expressed as mean ± SD. AIx% was calculated only for the patients whose inflexion was 
distinguishable in the waves assessed with both technologies, which happened for 53 
subjects. Furthermore, cSP comparison was performed in 71 subjects, since the pressure 
of the remaining 5 was miscalculated by the software of one or both devices. 
Differences between techniques were tested by sample student t-test. ICC, usually 
applied to evaluate different techniques outputs to acquire the same variable in the same 
subject, and Bland-Altman plots were used in the analysis of the POFpen measurements 
accuracy. An ICC between 0.7 and 0.8 was considered to represent a strong agreement 
between techniques and a correlation higher than 0.8 a very strong agreement. A p < 0.05 
was taken as significant. The statistical calculations were performed with IBM SPSS 
Statistics 23. 
6.2. Results   
The demographic and clinical characteristics of the patients that entered the study are 
presented on Table 6.1. It can be verified that the population, with an average age of 53 
years old, was overweight, 40 % had dyslipidaemia, 16 % diabetes and 93 % 
hypertension, whereas 34 % were smokers or ex-smokers. Not all the subjects were 
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actuality hypertensives because in the consultation patients with suspected hypertension 
are also seen, diagnosis that was not always confirmed. 7 % of the patients who entered 
the study had a previous acute myocardial infarction and 12 % a previous cerebrovascular 
event, considering transient ischemic attack, hemorrhagic or ischemic stroke. The PWV, 
assessed with Complior, presented a mean value of 9.02 ± 2.67 m/s.  
Table 6.1. Demographic and clinical characteristics of the study subjects. 
 
 
 
 
 
 
 
 
 
In Fig. 6.1 three examples of superimposed waves detected with Complior and POFpen 
can be seen, showing the morphology similarity in type-A, B and C waves.  
 
Figure 6.1. Examples of type-A, B and C waves acquired with Complior and POFpen. 
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Variables Quantity 
Male gender, nsub (%) 42 (55) 
Age, years ± SD 53 ± 16 
BMI, kg/m
2 
± SD 28 ± 5 
Dyslipidemia, nsub (%) 
Diabetes, nsub (%) 
Hypertension, nsub (%) 
Smoking habits: 
Never smoked, nsub (%) 
Ex-smoker (> 1 year), nsub (%) 
Current smoker, nsub (%) 
PWV (m.s
-1
) 
Acute myocardial infarction, nsub (%) 
Cerebrovascular accident, nsub (%) 
30 (40) 
12 (16) 
71 (93) 
 
50 (66) 
15 (20) 
11 (14) 
9.02 ± 2.67 
5 (7) 
9 (12) 
Brachial BP  
Systolic pressure (mmHg ± SD) 
Diastolic pressure (mmHg ± SD) 
Mean arterial pressure (mmHg ± SD) 
 
136 ± 20 
81 ± 11 
100 ± 12 
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The superimposition of the pulses showed an average RMSD of 0.13 ± 0.05 a. u., and a 
mean ICC of 0.96 ± 0.03. Similarly to the pre-clinical tests, the FF% from distension and 
pressure waves differed from each other in approximately 10 ± 4 %, Complior presented a 
mean FF% of 39 ± 4 % and POFpen 49 ± 4 %.  
Regarding the frequency components, the maximum verified difference was in the 
1st harmonic (0.02 a. u.). Nevertheless, all the harmonics were significantly correlated 
accordingly to intraclass correlation analysis. 
As concerns to AIx%, the results scatter plotting, presented in Fig. 6.2a, shows a slope of 
0.80, with an ICC of 0.91 (p < 0.001). As can be verified in Bland-Altman graph (Fig. 6.2b), 
a mean difference of 1.89 ± 12.22 % was found, and almost all the values were within the 
confidence interval, showing a good accuracy profile.  
 
  a)                                                                  b) 
Figure 6.2. AIx estimated with POFpen and Complior as: a) scatter plot with linear 
regression (ICC = 0.91 (p < 0.001), slope = 0.80 ± 0.08) and b) Bland-Altman plot (nsub = 53). 
 
As performed in the pre-clinical study, for cSP calculation the POFpen FF% were 
corrected subtracting 10 % of the original value for each subject.  
After the correction, the resulting mean cSP pressure difference was -1.2 ± 5.2 mmHg. 
The dispersion profile was analysed (see Fig. 6.3a), having presented a slope of 1.00 ± 
0.03 and an ICC of 0.98 (p < 0.001). Bland-Altman analysis showed once again a good 
accuracy profile, as can be observed in Fig. 6.3b. 
In this work it was also performed correlation tests between arterial stiffness, evaluated by 
means of PWV with Complior, and AIx% and cSP assessed with both techniques. As can 
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be verified in Table 6.2, cSP data from both techniques was highly correlated with arterial 
stiffness. On the other hand, only AIx% calculated from the POFpen waves was 
significantly correlated with PWV.  
 
a)                                                                    b) 
Figure 6.3. cSP estimated with POFpen and Complior as: a) scatter plot and linear 
regression (ICC= 0.98, slope = 1.00 ± 0.03) and b) Bland-Altman plot (nsub = 71).  
Table 6.2. ICC and significance grade between PWV and AIX% and cSP for both techniques 
(**very significant, 
ns
non-significant) for a confidence level of 95%. 
 AIx% POFpen AIx% Complior cSP POFpen cSP Complior 
ICC PWV 0.389 0.155 0.672 0.644 
p 0.004** 0.184
ns
 < 0.001** < 0.001** 
 
6.3. Discussion 
With this study it was intended to clinically evaluate the carotid pulse acquisition with the 
POFpen using as reference the Complior analyse. This commercial device has been 
extensively used for PWV, cSP and AIx% assessment. Literature reports recent data on 
Complior invasive and non-invasive validation, evaluating its performance with reference 
to intra-aortic and SphygmoCor® pulses, respectively. Complior cSP and AIx% 
comparison with invasive pressure waves presented the mean difference in pressure of 
1.80 ± 4.20 mmHg and AIx% of 0.24 ± 0.84 % (Pereira et al. 2014). Regarding the 
non-invasive validation with SphygmoCor, it was reported a cSP difference between 
techniques of -0.7 ± 5.6 mmHg (Stea et al. 2014). This study stated that Complior and 
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SphygmoCor are interchangeable, and being the devices more used in epidemiologic 
studies, it was considered that any of the two devices could be used as reference in this 
validation study. 
Measurements were performed in 76 patients, a similar number of subjects of other 
clinical evaluation studies, such as the comparison of arterial tonometers reported by 
Zhang et al. in 2013, in which 66 subjects were enrolled.  
Regarding the present study, results showed that waves acquired with POFpen and 
Complior are superimposable, having a mean deviation between techniques of about 
13 ± 5 %, and an average correlation coefficient of 0.96 ± 0.03. It was also verified that 
the 8 harmonics amplitudes were significantly correlated.  
Concerning the AIx% values, a very strong correlation, with an ICC coefficient of 0.91 
(p < 0.001), was found between techniques as well as a residual mean difference 
of -1.89 ± 12.22 %. Bland-Altman analysis showed that the majority of the values were 
within the confidence interval, showing a good accuracy profile without visible bias. The 
AIx% is usually associated with a greater standard deviation between techniques, 
however the results are within the range presented in the validation of commercial devices 
(Zhang et al. 2013).  
FF% was calculated for all the curves, and similarly to the pre-clinical study, the distension 
waves presented higher values than pressure waveforms in approximately 10 %. After 
FF% correction, the cSP difference was -1.2 ± 5.2 mmHg, with the POFpen slightly 
overestimating cSP, presenting a strong ICC of 0.98 (p < 0.001) between techniques. The 
Bland-Altman analysis showed a good accuracy profile for the device as well as absence 
of bias. These results are once more in the range of other studies evaluating commercial 
devices (García-Ortiz et al. 2012; Agnoletti et al. 2014). 
Lastly, correlation studies between cSP and AIx% values, assessed with both techniques, 
and arterial stiffness, measured as PWV, were carried out. cSP data from both devices 
were highly correlated with arterial stiffness, with ICCs of 0.672 and 0.644 (p < 0.001) for 
POFpen and Complior, respectively. On the other hand, for AIx%, only the values 
calculated from the POFpen waves were significantly correlated with PWV (ICC = 0.389, 
p < 0.005). A possible explanation for this finding is that AIx% assessed with POFpen, 
being calculated from distension waves, seems to be more related with arterial 
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viscoelastic properties, and consequently with arterial stiffness, than AIx% usually inferred 
from pressure waves. 
6.4. Study limitations and future perspectives 
A limitation of the current study was the fact that the acquisitions could not be made in a 
random order, due to logistic issues. As future work, it is proposed to assess the 
inter-operator repeatability with pulse wave acquisitions performed in a random order. The 
other identified limitation, which is transversal to the non-invasive validations methods, 
was the non-simultaneity of the pulses acquisition.  
6.5. Conclusions 
This work had the goal to clinically evaluate POFpen in the assessment of the central 
arterial pulse for AIx% and cSP calculation, using a commercial piezoelectric probe as 
reference. For both parameters, strong correlations were found. Additionally, AIx% data 
estimated with POFpen were significantly correlated with PWV, which do not happed with 
the AIx% values assessed with the piezoelectric device. The results validate POFpen as a 
promising low cost and simple solution for arterial pulse acquisition. Nevertheless, in order 
to support these findings, invasive evaluation was also performed and the results are 
presented in the next chapter. 
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The aim of this study was to evaluate the accuracy of carotid pulse waveform assessment 
with a new plastic optical fiber sensor, using as reference intra-aortic pressure readings.  
 
 
 
 
 
 
The aim of the work presented in this chapter was to evaluate the accuracy of carotid 
pulse waveform assessment with POFpen, using as reference intra-aortic pressure 
readings. This cross-sectional study included 29 subjects referenced for cardiac 
catheterization. Pulse waves were obtained simultaneously in the root of the aorta, and in 
the right common carotid with POFpen. The pulse waves were compared by RMSD%, 
FF% first 8th harmonic’s amplitude, AIx% and cSP. The PWA indexes assessed with the 
POFpen demonstrated similar accuracy to non-invasive commercial devices. The results 
indicate that the POFpen performance is suitable to acquire carotid pulse wave.  
7 
Inv sive clinical e aluation 
 
 
: 
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7.1. Materials and methods 
This cross-sectional study, performed at the CHUC-HG (Coimbra, Portugal), aimed to 
evaluate the similarity between carotid distension waves acquired with POFpen and 
intra-aortic pulse waves. The data was collected in 7 random days, in a period of 
approximately 4 months. 37 patients with suspected coronary artery disease and/or 
valvulopathies, who underwent cardiac catheterization, were recruited.  
For the patients entering the study, they could not present arrhythmia, premature 
ventricular beats, respiratory problems, movement artefacts and/or severe mental 
problems, which happened for 29 patients. Clinical information was obtained from the 
patients and respective clinical files, including age, sex, weight, height, personal clinical 
history, smoking habits, and pharmacological treatment. The study was approved by the 
local ethics committee. 
The intra-aortic pulse waves and pressure values were assessed during catheterization, 
which was performed using a 6-Fr Judkins right catheter connected to a pressure 
transducer, with a saline infusion system. The equipment used was the Siemens Artis Zee 
with AXIOM Sensis hemodynamic recording system. The acquisition of the aortic and the 
carotid waves was made simultaneously. After each acquisition, that took no longer than 2 
minutes, brachial BP was measured using a commercial pressure cuff (M6 Comfort, 
OMRON).  
The pulses similarity analysis was performed by evaluating their RMSD, FF% and 
amplitude of the first 8 harmonics. The point-to-point correlation between the curves, 
obtained with both techniques, was also carried out for all patients.  
The AIx% evaluated by both techniques was calculated for the patients whose pulse 
waves presented a clear incisura, in both intra-aortic and POFpen waves, which 
happened for 21 individuals. Respecting to the cSP appraisal with POFpen device, it was 
only performed in the subjects that presented pSP equal or higher than invasive cSP, 
since aortic-brachial pressure amplification cannot be negative, which was achieved for 15 
individuals.  
Data was compared by paired student t-tests and expressed as mean ± SD. Similarly to 
the work presented in the last chapter, the correlation between procedures was analysed 
by ICC. An ICC between 0.7 and 0.8 was considered to represent a strong correlation 
between techniques, and an ICC higher than 0.8, very strong. Finally, Bland-Altman plots 
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were used to evaluate agreement between cSP estimated with both invasive and 
non-invasive techniques. Two-tailed values of p < 0.05 were considered statistically 
significant. 
7.2. Results 
The baseline characteristics of the cohort enrolled in the study are showed in Table 7.1. 
The group was majorly composed by male subjects (69 %), with ages between 47 and 88 
years old. Regarding to CV risk factors, the subjects were slightly overweight, with a BMI 
of 26 ± 4 kg/m2, 69 % presented dyslipidemia, 24 % diabetes, 59 % had reported HT and 
24 % were or had been smokers. 24 % had past coronary artery bypass grafting, and 
59 % were submitted to coronary angioplasty. 28 and 21 % had suffered acute myocardial 
infarction and/or stroke, respectively. The subjects mean pSP was 145 ± 28 mmHg.  
Table 7.1. Demographic and clinical characteristics of the 29 subjects enrolled in the study. 
 
 
 
 
 
 
 
 
 
 
In Fig 7.1, examples of superimposed invasive and POFpen waveforms recorded in 4 
patients are presented, showing that both curves have similar morphology. Potential 
differences in the pulse wave morphologies, were studied in the time and frequency 
domains. The RMSD% obtained was 11 ± 3 % and the difference in FF% was 7 ± 3 %. 
The pulses point-by-point ICC evaluation showed a very strong mean correlation of 
0.97 ± 0.02.  
 
Variables Quantity 
Male gender, nsub (%) 20 (69) 
Age, years ± SD 69 ± 11 
Weight, kg ± SD 72 ± 13 
Height, m ± SD 1.66 ± 0.09 
BMI, kg/m
2 
± SD 26 ± 4 
Dyslipidemia, nsub (%) 
Diabetes, nsub (%) 
Reported Hypertension, nsub (%) 
Smoking habits: 
Never smoked, nsub (%) 
Ex-smoker (>1year), nsub (%) 
Current smoker, nsub (%) 
Coronary Artery Bypass Grafting, nsub (%) 
Coronary Angioplasty, nsub (%) 
Acute Myocardial Infarction, nsub (%) 
Stroke, nsub (%) 
20 (69) 
7 (24) 
17 (59) 
 
22 (76) 
4 (14) 
3 (10) 
7 (24) 
17 (59) 
8 (28) 
6 (21) 
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Figure 7.1. Superimposed intra-aortic and POFpen waves for 4 patients. 
Results from the frequency study, presented on Fig. 7.2 and Table 7.2, show that the 
average harmonics amplitude differences are below 1 %. Paired t-tests demonstrated that 
there are not significant differences between the first 7 harmonics (p < 0.05) and ICC 
demonstrated that all the harmonics are correlated, except for the 7th.  
 
 Figure 7.2. Fourier decomposition of the intra-aortic and POFpen acquired 
waveforms, data represented as average amplitude with respective standard deviation. 
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Table 7.2. Frequency domain analysis – harmonics’ amplitude (values as mean ± SD, 
ND - non-significantly different, D – significantly different).  
Harmonics 
Invasive 
signal 
POFpen signal 
Paired 
t-tests 
p ICC p 
1 0.398 ± 0.029 0.398 ± 0.029 ND 0.949 0.50 0.040 
2 0.170 ± 0.019 0.166 ± 0.020 ND 0.443 0.60 0.011 
3 0.066 ± 0.024 0.059 ± 0.022 ND 0.561 0.73 0.000 
4 0.040 ± 0.018 0.042 ± 0.022 ND 0.585 0.71 0.001 
5 0.040 ± 0.021 0.037 ± 0.016 ND 0.317 0.74 0.000 
6 0.024 ± 0.017 0.023 ± 0.010 ND 0.720 0.63 0.006 
7 0.015 ± 0.009 0.014 ± 0.010 ND 0.539 0.46 0.055 
8 0.010 ± 0.007 0.014 ± 0.007 D 0.019 0.61 0.044 
 
In relation to AIx% values, linear regression was performed to compare both techniques, 
as can be seen on Fig. 7.3a. The results presented a strong ICC of 0.79 (p < 0.001), even 
though the values assessed with POFpen presented a smaller coefficient of variance 
(1.04) than the invasive signals (1.36). Fig. 7.3b shows that the great majority of the data 
are within the confidence interval, with POFpen underestimating AIx% by 3.7 ± 12.5 %.  
 
a)                                                          b) 
Figure 7.3. AIx estimated with POFpen and intra-aortic pressure probe as: a) scatter plot 
with linear regression (ICC = 0.79 (p < 0.001), slope = 0.43 ± 0.08) and b) Bland-Altman plot. 
 
The cSP results can be seen on Fig. 7.4. The scatter plot (see Fig. 7.4a) showed a linear 
tendency, with a very strong ICC of 0.94 (p < 0.001). In the Bland-Altman plot (Fig 7.4b), 
despite a cSP underestimation by POFpen of 4.2 ± 11.1 mmHg, it can be seen that all 
data points are within the confidence interval, without visible bias.  
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a)                                                               b) 
Figure 7.4. cSP estimated with POFpen and intra-aortic pressure probe as: a) scatter plot 
and linear regression (ICC = 0.94 (p < 0.001); slope = 0.96 ± 0.14) and b) Bland-Altman plot. 
 
7.3. Discussion 
This work had the main goal to ascertain the accuracy of POFpen device in acquiring 
central pulse waves, performing simultaneous invasive pressure measurements, in the 
aortic root of 29 patients.  
Invasive comparison is considered the gold-standard process to validate non-invasive 
devices for central pulse waveform acquisition. Studies employing commercial devices, as 
Complior Analyse® and SphygmoCor®, had performed this kind of evaluation. In 
Ding et al. 2011 the invasive validation of SphygmoCor® and Omron HEM9000-AI® is 
presented, by estimating cSP in 33 subjects. The results were significantly associated with 
the invasive measurement in the ascending aorta, with a Pearson’s correlation coefficient 
of 0.91 (p < 0.001) and 0.90 (p < 0.001), for SphygmoCor and Omron, respectively. It was 
also reported that both devices underestimated cSP with a difference of −15 mmHg for 
SphygmoCor and −2 mmHg for Omron.  
In 2013, Sztrymf et al. reported a validation study complying 12 patients, in which radial 
pulses obtained with Complior and invasive acquisitions were compared, showing that 
there was no statistical difference in the amplitude of the harmonics calculated from both 
signals and the form factor differences between techniques were 4.2 ± 2.8 %. Pereira 
et al. 2004 reported another invasive study, in 15 patients, comparing carotid pulses 
assessed by Complior and aortic invasive catheter, achieving an underestimation of cSP 
calculation of 0.80 ± 4.20 mmHg.  
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In the present study the acquired signals with both techniques were overlapped, being 
verified an overall deviation of 11 ± 4 %, with a FF% difference of 7 ± 3 %, which is in 
agreement with the results found in Kips et al. 2010 (6 %), and close to the value reported 
in Sztrymf et al. 2013 (4 %). It should be noticed that in this case, besides the 
viscoelasticity of the arteries, the different acquisition locations also contribute to 
dissimilarities in the pulses morphology. However, a very strong mean ICC of 0.97 ± 0.02 
was obtained in the point-by-point correlation analysis between pulse waves.  
In the frequency domain, the differences in the harmonic amplitudes never reached 0.01 
a.u., with overall differences meaningfully inferior to the presented in Sztrymf et al. 2013. 
Statistically, the first 7th harmonics were not significantly different and all the harmonics, 
excepting the 7th, were correlated.  
Regarding AIx%, an ICC of 0.79 (p < 0.001) was obtained, for a mean difference between 
techniques of less than 4%. However, a positive bias was noticed, appearing to be related 
to the lower coefficient of variance of POFpen results, 1.04 vs 1.36 for invasive waves, 
which is probably caused by the different nature of the pulses as well as different arterial 
locations.  
Finally, cSP values were compared for 15 subjects. A high pressure variability was 
verified between the pulses acquisition and the brachial pressure measurement moments. 
Therefore, several times the pSP assessed after the pulses acquisition presented a lower 
value than cSP and, consequently, for these patients were only compared the waveforms 
and not cSP. Even though this occurrence, this study achieved the minimum number of 
subjects usually entering in invasive validations of commercial tonometers (Sztrymf et al. 
2013 and Pereira et al. 2014).  
The cSP statistical analysis showed an ICC of 0.94 (p < 0.001) and the Bland-Altman plot 
a mean pressure difference of -4.2 ± 11.1 mmHg, with all values between the confidence 
interval and without observed bias. POFpen seems to underestimate cSP, similarly to 
other commercial techniques (Ding et al. 2011; Pucci et al. 2013).  
7.4. Study limitations 
As study limitations, it should be referred the age and health conditions of the subjects, 
who were in its great majority doing catheterization in an urgent context. This constraint is 
transversal to all invasive validations, since it would be unethical to appeal a healthy 
person to a catheterization without a clinical justification. Another limitation was the 
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impossibility to perform intra-carotid readings, due to the fact that it would also be 
unethical to submit the patients to carotid exploring, once the catheter navigation on the 
carotid artery presents a much higher risk to the patient than in aorta, which is in the path 
of the regular exam.  
An additional important limitation was the impossibility to take in consideration all the 
patients data to calculate cSP. In the present study, a great quantity of subjects presented 
pSP, measured right after the acquisitions, lower than cSP measured invasively. This 
could be owed to inaccuracies on the brachial pressure estimation, natural pressure 
variability of the subjects, or rapid nitrites effects on vasodilatation, which are commonly 
applied. Due to this registered negative pressure amplification throughout the 
aortic-brachial arterial path, which is not supposed to happen physiologically (Laurent 
et al. 2006), it was made the decision of not comparing the cSP values assessed by the 
two techniques in those situations.  
7.5. Conclusions 
In the presented cross-sectional study, it was showed that the waves estimated by both 
techniques presented a very strong mean correlation and harmonic’s amplitude 
differences not higher that 0.01 a. u.. AIx% obtained with the two techniques presented a 
strong ICC. Concerning the cSP results, a very strong correlation of 0.94 (p < 0.001) was 
found, with an estimated difference between techniques within the range verified in 
commercial devices. It was concluded that POFpen is accurate in the acquisition of 
carotid pulse waveforms, being a simple and low cost alternative to tonometry in the 
appraisal of PWA and cSP.  
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8.1. Conclusions  
This thesis, structured in 8 chapters, started by revising the importance of blood pressure 
monitoring, at peripheral and central locations, in hypertension assessment and CVD 
prevention. Reviewing the literature, it was verified that central pressure and other arterial 
stiffness indexes are yet no regularly used in the clinical context, even though several 
research groups have been studied and demonstrating their prognostic values. Several 
reasons were pointed out as explanation of the underuse of these techniques, such as 
training need for its execution and the high cost of the devices to perform carotid pulse 
acquisition.  
The application of OFS emerged as a suitable technology to acquire carotid pulses, as 
they present several application advantages over conventional electromechanical 
solutions. In the biomedical field, they are highlighted by the high sensitivity, stability, 
immunity to electromagnetic radiation, safety and possibility of low cost designs. In the 
development of the present work, three optical fibre systems were developed to assess 
the carotid arterial pulse, one of them having been clinically evaluated. 
Before the presentation of the developed work and obtained results, two chapters 
(2 and 3) introduced the general concepts on arterial stiffness, central haemodynamics 
and optical fibre sensors. Since this thesis is organized as the sequence of the published 
papers, the two referred chapters embody the theoretical background for all the following. 
In Chapter 4, the three developed probes, FBGbox, FBGpen and POFpen were 
presented. In the table 8.1, the main features regarding sensitivity and resolution, as well 
as robustness, user-friendliness and cost of the three probes, are compared. The first 
probe was developed to analyse the feasibility of detecting the carotid pulse with optical 
fibre sensors. The human testing delivered promising results, even though the sensor 
shape and robustness needed improvements to be a ready to use prototype for the 
clinical environment.  
The constraints of FBGbox, were overtaken by the development of FBGpen. From the one 
version to the other, sensitivity was greatly improved (≈ 10 times). However, this 
upgrading happed with the sacrifice of the dynamic range, which drastically decreased. In 
spite of that, in the individuals testing, the sensor allowed to acquire the pulse wave in all 
the enrolled subjects, presenting its robustness and user-friendliness greatly improved.  
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The recent low cost devices for central pressure estimation based on oscillometry, derive 
central pressure directly from the brachial arterial pulse, which is not necessarily accurate 
(Kips 2011). On the other hand, the remaining devices are expensive, which can be an 
obstacle to the central arterial appraisal in primary care as well as in research purposes. 
Therefore a second goal of the work was to develop a low cost solution. To achieve this 
aim, an approach based on intensity modulation was implemented with the development 
of POFpen. For its attainment, an all-plastic pen, design to support a POF, was fabricated 
recurring to a 3-D printer. The basic material needed for its assembly is a 2x1 POF 
coupler, a photodetector, a LED, a Bluetooth® module and the controlling electronics. The 
probe works in reflection, therefore to assess carotid pulse, a small round adhesive 
reflector should be placed in the neck area, where the highest pulsatility was felt, to 
acquire the pulse wave. As can be analysed from Table 8.1, POFpen allied the 
advantages of FBGbox and FBGpen to low cost and robustness. 
 Table 8.1. Features of the three developed probes 
 FBGbox FBGpen POFpen 
Sensitivity 2.0 pm/µm 21.2 pm/µm 727.2 µV/µm 
Interrogation 
systems resolution 
0.5 pm 0.5 pm 38.15 µV 
Displacement 
resolution 
0.25 µm 0.02 µm 0.05 µm 
Displacement 
range 
280 μm 16 μm 295 μm 
Robustness* ++ +++ +++++ 
User-friendliness* ++ ++++ ++++ 
Cost* ++++ ++++ + 
    *Qualitative variable (minimum +, maximum +++++) 
 
No clear guidelines exist to the validation and certification of the new devices for central 
arterial pressure assessment. Additionally, the literature review presented on Chapter 2 
showed that commercial devices demonstrate considerable differences in cSP calculation 
in relation to the invasive gold-standard. These differences support the need for better 
regulation for the devices validation, as well as their calibration methods. The Artery 
Society have been working on creating guidelines and standards to the validation of new 
devices, as happened already for the PWV devices, whose certification and calibration 
methods are well stablished (Wilkinson et al. 2010). The task has been more difficult to 
 Optical fibre sensors as a non-invasive technology to the central arterial pressure assessment 
 
110 
 
accomplish for PWA and cSP devices, for which an agreement on the best calibration 
algorithm and validation technique was not reached yet.  
The clinical evaluation of POFpen was then performed according to the studies found in 
the literature including commercial devices, in which the new technologies are usually 
compared with the most ancients and widely applied devices worldwide, such as 
SphygmoCor® and Complior®, and with the invasive pressure assessment gold-standard. 
Some commercial devices have theirs calibration algorithms protected, therefore is not 
accurate to use a device with a different calibration method as a reference in a validation 
study. For this dissertation, it was chosen to non-invasively evaluate POFpen comparing it 
with Complior® Analyse, since both devices use the same method for the arterial pulses 
calibration. Lastly, the invasively evaluation was performed comparing POFpen results 
with pressure waves acquired at the aortic lumen, in a catheterization context.  
The pre-clinical study had as main goal to ascertain and gather evidence of POFpen 
performance, before its proposal for clinical evaluation. In that study, POFpen pulse 
waves, assessed in healthy young subjects, were compared with the Complior Analyse 
carotid pulses. The POFpen waves presented FF% higher than Complior’s, agreeing with 
Kips et al. 2010 study, in which is reported a difference between distension and pressure 
waves from about 6 %. Even though the FF% difference, a very strong correlation was 
attained for the cSP values obtained with the two techniques (r = 0.99, p < 0.001) as well 
as a very small cSP difference, which after FF% correction, was of 0.6 ± 2.4 mmHg. The 
encouraging results from this pre-clinical testing reinforced that the POFpen presented the 
performance needed to meet the application requirements, having been the basis for its 
clinical evaluation proposal. 
The clinical evaluation begin with the non-invasive study, using as reference the Complior 
Analyse, performed in 76 subjects from the hypertension consultation of the cardiology 
service of CHBV. It was found a main difference in FF% of approximately 10%, in 
agreement with the value obtained in the pre-clinical study, nevertheless a very strong 
correlation was found between the pulse waves (r = 0.96 ± 0.03). In this study the 
assessed AIx% was compared for 53 subjects, having been obtained a deviation 
of -1.89 ± 12.22% (r = 0.91, p < 0.001). The cSP difference, after FF% correction, 
was -1.2 ± 5.2 mmHg, with an r = 0.98 (p < 0.001). The reported values are very close to 
the ones presented in similar studies (Vermeersch et al. 2008; García-Ortiz et al. 2012; 
Agnotelli et al. 2014, Stea et al. 2014). 
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Concerning the invasive study, the waves measured with both techniques presented a 
mean correlation of 0.97 ± 0.02 and harmonics amplitude differences not higher that 0.01. 
The appraised AIx% and cSP values demonstrated a strong (0.79, p < 0.001) and a very 
strong (0.94, p < 0.001) ICC, respectively. Once more, the difference between techniques 
was within the range verified for commercial devices (Zuo et al. 2010; Pucci et al. 2013). It 
was concluded that POFpen is accurate, being a simple and low cost solution for 
acquisition of carotid pulse waves for PWA and cSP estimation. 
The resume of the results obtained in both invasive and non-invasive evaluation are 
presented on Table 8.2. Analysing all the studies, it can be seen that for RMSD and FF%, 
better results were achieved when comparing POFpen to the pressure intra-arterial 
readings, allowing to calculate cSP and obtaining results in the order of the commercially 
available devices, without the need of FF% correction. When analysing the point-by-point 
correlation performed between the pulses, both studies presented very strong ICC and 
similar results. 
Comparing the harmonics amplitude differences, it was verified that its differences 
between amplitudes were residual, and for the non-invasive and invasive studies, all the 
harmonics were correlated, except for the 7th harmonic of the invasive data. It was not 
attributed importance to this result, since the main pulse energy is in the first 5 harmonics, 
having the 7th and 8th, residual amplitudes, as can be verified in table 7.2 (Chapter 7). 
Table 8.2. Comparison of the results obtained in the invasive and non-invasive studies. 
Variable                                      Study                                      
Pre-clinical 
Non-invasive 
Non-invasive Invasive 
RMSD (%) 14 ± 2 13 ± 5 11 ± 3 
ΔFF (%) 10 ± 2 10 ± 2 7 ± 3 
Harmonic’s maximum amplitude 
difference (a. u.) 
0.01  0.02 0.01 
Point-by-point waves correlation - 0.96 ± 0.03 0.97 ± 0.02 
ΔAIx (%) - 1.9 ± 12.2 % 3.7 ± 12.5 % 
AIx Correlation - 0.91 (p < 0.001) 0.79 (p < 0.001) 
ΔcSP (mmHg) 0.6 ± 2.4* -1.2 ± 5.2* -4.2 ± 11.1 
cSP correlation 0.99 (p < 0.001) 0.98 (p < 0.001) 0.94 (p < 0.001) 
    *cSP obtained after FF% correction 
Regarding AIx values, the non-invasive comparison achieved better results. In the case of 
AIx, no assumptions are made, since its calculation is not pressure dependent, and 
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consequently, comparisons in the same arterial location should retrieve better results. 
Nevertheless, both studies results are within the values of correlation and difference found 
for commercial devices (Vermeersch et al. 2008; Wassertheurer et al. 2010; García-Ortiz 
et al. 2012). 
Lastly, with reference to cSP values, important differences were verified in the invasive 
and non-invasive studies. In the first, being aware of the FF% difference detected 
between both the non-invasive techniques, the performed calibration procedure complied 
the subtraction of 10 % to the FF% POFpen values before calculate cSP. Procedure that 
results in a minimal cSP difference between devices. For the non-invasive study, no FF% 
correction was performed, proceeding to the direct calibration of the waves. Even though 
presenting a higher difference than in the non-invasive studies, the reported value is 
within the range found in the literature.  
In resume, the main goals of the work were achieved by the development of the three 
optical fibre prototypes and the evaluation of POFpen in a total of 120 subjects, ranging 
from young and healthy to hypertensive, with past cardiovascular events and elderly 
people. Since the results were in agreement with the accuracy of the commercial devices, 
it is concluded that the POFpen is a valid new technology in cSP assessment. 
8.2. Future work perspectives 
In the future, some clinical and technologic studies are planned to be carried out. The first 
is the cSP variation assessment before and after exercise, in order to continue the 
preliminary test described in section 4.3.4. With this work, the recovery time of the central 
and the brachial pressures to the basal levels, after exercise, is intended to be analysed. 
Other work is already scheduled, in which is envisioned the study of the cSP and central 
arterial wave morphology in the myocardial infarction, with the main goal of evaluating the 
prognostic value of PWA and cSP in the infarction recover. 
In the technologic field, it has already started the development of a new approach to fix 
the intensity sensor in the neck, in order to measure cSP during longer periods of time, 
without the need of medical help (Leitão et al. 2016). The design and implementation of a 
PWV device, using the POFpen technology, is also planned. Finally, the conception of 
new wearable sensing networks on physical parameters assessment such as plantar 
pressure, temperature, heart and respiratory rates, had also already started (Domingues 
et al. 2016). 
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